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Abstract 
The current study investigated the prevalence of the non-medical use of prescription 
stimulant medication (active use in the absence of a valid prescription) by graduate 
students. The project sought to determine whether the rate of non-medical use in this 
population would be commensurate with usage rates observed in the undergraduate, law, 
and medical student populations. The study also explored the relationship between 
perceived knowledge and safety of stimulant medications and non-medical use. 
Additionally, the study explored the relationship between non-medical use of prescription 
stimulants with academic self-efficacy, psychological factors (anxiety, depression and 
stress), and internal restlessness. The present study recruited 807 graduate students from 
universities located in five geographic regions of the United States. Participants 
completed measures concerning demographic information, stimulant use, internal 
restlessness, academic self-efficacy, and psychological distress. Past-year rates of self-
reported non-medical use were determined to be 5.9%, with overall lifetime prevalence of 
17.5%. Motivations for use reported by participants were both academic and social in 
nature. Self-reported non-medical use of prescription stimulant medications was observed 
to be significantly correlated with self-reported levels of anxiety, depression, and stress, 
with various aspects of internal restlessness, and with perceived safety of the 
medications. Internal restlessness and the perception of safety of stimulant medications 
were observed to partially predict the non-medical use of prescription stimulants. 
Effective prevention and education efforts are needed to help address the non-medical use 
of prescription stimulants by graduate students on university campuses. 
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Introduction 
Attention-deficit/hyperactivity disorder (ADHD) is characterized by deficits in 
sustained attention, hyperactive behavior, and impulsive behavior, is estimated to affect 
3% to 7% of the school age population and 2% to 4% of the adult population (APA, 
2000; Barkley, 2006). Although specific data on the proportion of university students 
with ADHD is not available, recent research has indicated that ADHD symptomatology 
has been observed in between 2% and 10% of university students (Garnier-Dykstra, 
Gillian, Pinchevsky, Caldeira, Vincent & Arria, 2010; Heiligstein, Conyers, Berns & 
Smith, 1998; McKee, 2008; Weyandt, Linterman & Rice, 1995).  Approximately 50% of 
students receiving disability support services on university campuses receive such 
services for ADHD (Wolf, Simkowitz & Carlson, 2009).  Although once conceptualized 
as a disorder of childhood (DuPaul, Guevermont, & Barkley (1991), several recent 
studies have suggested a significant proportion of individuals who are diagnosed with 
ADHD in childhood continue to display symptoms of the disorder into adulthood 
(Barkley, Fischer, Smallish, & Fletcher, 2002; Biederman, Mick & Faraone, 2000; 
Torgersen, Gjervan & Rasmussen, 2006). Furthermore, increasing numbers of students 
with ADHD are pursuing a university education (Wolf 2001; Wolf, Simkowitz, & 
Carlson, 2009), although the exact rates of ADHD among college students is unknown 
due to privacy protection for students with disabilities under the Americans with 
Disabilities Act (1991). Preliminary studies suggest that a significant percentage of 
college students (estimates range from 2% to 9%) report elevated ADHD 
symptomatology, which has been associated with increased risk for impaired academic, 
social, and psychological functioning (DuPaul, Weyandt, O’Dell, & Varejao, 2009; 
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Overbey, Snell, & Callis, 2011; Norvilitis, Ingersoll, Zhang, & Jia, 2008; Weyandt, & 
DuPaul, 2006; Weyandt et al., 2003; Weyandt et al., 2009).  In one recent investigation 
based on data collected from a large, nationally representative sample of first year college 
students, 5% of participants reported having ADHD (Pryor, Hurtado, DeAngelo, Blake, 
& Tran, 2010). 
Treatment of ADHD in university students and other young adults is similar to 
treatment of children with ADHD with respect to the use of stimulant medication (e.g., 
Adderall, Ritalin, Vyvanse, Concerta). Stimulant medications are considered the “first-
line” of therapy for young adults, and the number of adolescents and college students 
treated with prescription stimulants for ADHD has steadily increased in the past decade 
(Advokat, 2010; Kolar, Keller, Golfinopoulos, Cumyn, Syer, & Hechtman, 2008; Wilens, 
Spencer, and Biederman, 1998). Although a significant body of research attests to the 
effectiveness of prescription stimulants in the treatment of individuals with ADHD 
(Biederman, Seidman, Petty, Fried, Doyle, Cohen, Kenealy, & Faraone, 2008; DuPaul, 
Weyandt, Rossi, Vilardo, O’Dell, Carson, Verdi, & Swentosky, 2012; Faraone, Faraone, 
& Glatt, 2010; Kolar et al., 2008; Wigal; 2009), the non-medical use of prescription 
stimulant medications among university students with and without ADHD has been cited 
as problematic in recent years.  
As psychostimulant medications have become increasingly available on college 
campuses, the use of stimulant medications without a prescription has been reported 
among undergraduate college students (DeSantis, Noar & Webb, 2010; DuPont, 
Coleman, Bucher, & Wilford, 2008; Dussault & Weyandt, 2013; Hall, Irwin, Bowman, 
Frankenberger & Jewett, 2005; Janusis & Weyandt, 2010; Judson & Langdon, 2009; Low 
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& Gendaszek, 2002; McCabe, Knight, Teter & Wechsler, 2005; Rabiner et al., 2009; 
Sharp & Rosen, 2007; Weyandt et al., 2009; White, Becker-Blease & Bishop, 2006). For 
the purposes of this investigation, the term “non-medical use” will be used to describe 
use of prescription stimulants by individuals other than those for whom the medication 
was prescribed. Non-medical use of prescription stimulants has likewise been observed 
among professional students and young adults (McNiel, Muzzin, DeWald, McCann, 
Schneiderman et al., 2011; Novak, Kroutil, Williams & Van Brunt, 2007; Prudhomme, 
Becker-Blease & Grace-Bishop, 2006). A number of psychological variables have been 
associated with the non-medical use of prescription stimulants, including depression 
(Huang, Dawson, Stinson, Hasin, Ruan, Saha, et al., 2006; Poulin, 2007; Teter, Falone, 
Cranford, Boyd & McCabe, 2010), anxiety (Dussault & Weyandt, 2013; Weyandt et al., 
2009), stress (Dussault & Weyandt, 2013; Peterkin, Crone, Sheridan & Wise, 2011), and 
internal (e.g. mental) restlessness (Dussault & Weyandt, 2013, Weyandt et al., 2009).  
 Although many studies have examined the non-medical use of stimulant 
medications among undergraduate university students, few studies have explored use 
among graduate students, a population which reports elevated levels of stress and 
psychological distress (Aktekin, Karaman, Senol, Erdem, Erengin et al., 2001; 
Dammeyer & Nunez, 1999; Dyrbye, Thomas & Shanafelt, 2006; Eisenberg, Gollust, 
Golberstein & Hefner, 2010; Helmers, Danoff, Steinert, Leyton & Young, 1997; 
McKinzie, Altamura, Burgoon & Bishop, 2006; Myers, Sweeney, Popick, Wesley, 
Bordfeld et al., 2012; Nelson, Dell’Oliver, Koch, & Buckler, 2001). Many undergraduate 
students report using stimulants during academic activities such as studying, test-taking 
and writing papers (DeSantis, Noar & Webb, 2010; DuPont et al., 2008; Rabiner et al., 
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2009; Sharp & Rosen, 2007; Weyandt et al., 2009), suggesting that graduate students 
may also be at increased risk for non-medical use of stimulant medication related to 
perceived academic demands.  Among undergraduates, academic performance has been 
observed to correlate negatively with the non-medical use of stimulants (Advokat, Guidry 
& Martino, 2008; Noar & Webb, 2009; McCabe et al., 2005; Weyandt et al., 2009).  
Academic functioning can be more difficult to assess among graduate students, who are 
often held to high minimum grade point averages in order to remain in their program 
(Silvera, Laeng & Dahl, 2003). The construct of academic self-efficacy, however, has 
been associated with overall academic functioning among students (Chemers, Hu & 
Garcia, 2001; Hackett, Betz, Casas, & Rocha-Singh, 1992; Pajares, 1996; Majer, 2009; 
Multon, Brown, & Lent, 1991; Poyrazli & Kavanough, 2006), raising the question of 
whether graduate students who report lower academic self-efficacy may use stimulants at 
a higher rate in order to cope with academic demands.  Previous investigations have 
likewise observed academic self-efficacy to correlate with symptoms of impaired 
psychological functioning among university students, including depression (Lavasani, 
Khezriazar, Amani, & Malahmadi, 2011) anxiety (Ghaderi, 2010; Lavasani, Khezriazar, 
Amani, & Malahmadi, 2011; Muris, 2002), and stress (Chemers, Hu, & Garcia, 2001; 
Lavasani, Khezriazar, Amani, & Malahmadi, 2011). 
 The present study investigated the prevalence of non-medical prescription 
stimulant use by graduate students in an attempt to determine whether the rate of non-
medical use in this population would be commensurate with usage rates observed in the 
undergraduate, law, and medical student populations. The study also attempted to discern 
the relationship between perceived knowledge and safety of stimulant medications and 
 6 
non-medical use, i.e. to determine whether students who reported using stimulants 
perceived greater self-knowledge about these medications and their safety. The study also 
attempted to explore the relationship between non-medical use of prescription stimulants 
and academic self-efficacy to explore whether students who felt less capable of achieving 
their academic goals were more likely to use stimulants without a prescription. Last, the 
study attempted to identify psychological factors including anxiety, depression and stress 
which predicted self-reported non-medical use of stimulants among graduate students. 
The overarching goal of the present study was to clarify the nature of non-medical 
stimulant use among graduate students to help identify sub-populations of graduate 
students who may be at increased risk for use, as well as to inform prevention and 
intervention strategies designed to address non-medical use of prescription stimulant 
medication among graduate students.  
University Students with ADHD: Academic, Social, and Psychological Functioning 
 In terms of academic functioning, college students with ADHD and those with 
significant ADHD symptomatology have been found to demonstrate impaired 
functioning when compared with their non-diagnosed peers. A 2010 study of 
undergraduate students diagnosed with ADHD (Advokat, Lane, & Luo, 2010) found that 
students with ADHD reported lower grade point averages than peers and reported more 
frequent withdrawal from courses in which they were enrolled. These findings supported 
results of previous investigation (Blase, Gilbert, Anastopoulos, Costello, Hoyle, 
Swartzwelder, & Rabiner, 2009; Heiligenstein, Guenther, Levy, Savino, & Fulwiler, 
1999), which found that undergraduate students diagnosed with ADHD reported lower 
mean grade point averages that non-diagnosed peers. Participants in the latter study were 
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also more likely to report being placed on academic probation and to report greater 
overall academic problems.  Both inattention and hyperactivity have been observed to 
uniquely contribute to GPA deficits among undergraduate students with ADHD 
(Schwanz, Palm, & Brallier, 2007).  
 A recent investigation into the specific types of academic challenges faced by 
undergraduates with ADHD (Lewandowski, Lovett, Codding & Gordon, 2008) indicated 
that university students with ADHD reported significantly more difficulties with having 
to re-read material repeatedly for comprehension, taking longer than peers to complete 
assignments, failing to finish timed tests, failing to perform well on standardized tests, 
and feeling as though they needed to work harder than peers to get good grades. Short-
term academic deficits have also been noted among university students with ADHD. A 
2013 investigation of various aspects of functioning among undergraduate students with 
ADHD found the students to report significantly lower grades than peer control group 
members on weekly reports of test, quiz, and writing assignment grades (Weyandt, 
DuPaul, Verdi, Rossi, Swentosky, O’Dell et al., 2013). These short-term academic 
challenges may ultimately threaten the long-term academic outcomes of college students 
with ADHD. Regarding the ability of undergraduate students with ADHD to complete 
their degree, a 2002 study found that young adults with ADHD were significantly less 
likely to graduate from college than a comparison group from the community (Murphy, 
Barkley, & Bush). Negative outcomes such as lower GPA and a reduced likelihood to 
graduate from their university within a set time period are not exclusive to university 
students in the United States, and a recent study in the U.K. observed similar outcomes 
among university undergraduates with ADHD (Pope, 2010).   
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 The social functioning of college students with ADHD has also been explored in 
several recent studies. Findings are limited, but suggest that college students with ADHD 
are more likely to report difficulty in interpersonal relations, less well-developed social 
skills, lower levels of social adjustment, and diminished levels of self-esteem. 
Specifically, students with ADHD have reported poorer quality of life in a number of 
distinct domains, including parent-child relations, political behavior, personal growth, 
and social desirability (Grenwald-Mayes, 2002). Shaw-Zirt, Popali-Lehane, Chaplin, & 
Bergman (2005) examined the social adjustment of university students with ADHD and 
noted significant impairments in Academic Adjustment, Social Adjustment, Personal-
Emotional Adjustment, Attachment and Goal Affiliation, and Total Adjustment of 
students with ADHD when compared with their non-afflicted peers. The same study 
found the students with ADHD to report significantly lower levels of perceived social 
skills and self-esteem as compared with peers.   
The social functioning of university students with ADHD also differs from that of 
peers when school-based and romantic social interactions are considered. Weyandt et al. 
(2013) observed university students with ADHD to report significantly impaired social 
adjustment related to their role as students, although no significant impairments were 
reported pertaining to social adjustment in social and leisure activities or relationships 
with family. Impaired functioning in social functioning in the context of an intimate 
relationship has also been observed among university students with ADHD, with 
diagnosed students reporting significantly lower levels of romantic satisfaction that peers 
(Overbey, Snell, & Callis, 2011). 
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The existing literature also suggests that the psychological functioning of college 
students with ADHD differs from that of peers without the disorder.  For example, 
Heiligenstein and Keeling (1995) found that undergraduate and graduate college students 
with ADHD were more likely than peers to exhibit symptoms of depression disorders, 
anxiety disorders, substance use disorders, and eating disorders. Regarding substance use, 
college students with ADHD have been found to be at greater risk than their peers for 
using alcohol and illicit substances, including tobacco, marijuana, and other illicit drugs 
(Blasé et al., 2009; Heiligenstein & Keeling, 1995; Murphy, Barkley & Bush, 2002; 
Upadhyaya et al. 2005). 
 Indeed, research has supported the notion that college students with ADHD 
experience elevated levels of psychological distress as compared those without the 
disorder. Specific differences include university students with ADHD reporting more 
depressive symptoms (Blase et al., 2009; Norvilitis, Ingersoll, Zhang, & Jia, 2008), lower 
emotional stability (Blase et al., 2009), greater levels of aggression (Kern, Rasmussen, 
Byrd, & Wittschen, 1999), greater internal restlessness, and greater overall psychological 
distress (Blase et al., 2009; Weyandt et al., 2003, Weyandt et al., 2009) as compared with 
peers. A more recent investigation by Weyandt et al. (2013) into the functioning of 
university students with ADHD found that these students reported significantly elevated 
levels of internalizing and externalizing symptomatology as compared with peer controls, 
including obsessive-compulsive symptomatology, depression, anxiety, hostility, and 
global psychological functioning.  
It is important to note that conclusions based on the extant literature concerning 
university students with ADHD literature are limited due to significant methodological 
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problems observed in many investigations (DuPaul, Weyandt, O’Dell & Varejao, 2009). 
Some studies have included students based solely on self-report of diagnostic status, 
without confirming the presence of clinical symptoms through an independent evaluation. 
Further, few studies appear to have comprehensively evaluated psychopathological 
symptoms among control participants. Lastly, although many studies investigating 
ADHD in college students have identified the impact that the disorder can have on 
student functioning in a number of distinct areas, few have systematically examined 
multiple areas of functioning in a single sample of students.  It is also important to note 
that the body of research concerning the academic, social, and psychological functioning 
of university students with ADHD focuses heavily on undergraduate students, and largely 
excludes graduate students. It seems likely that, given the expressed deficits in academic 
functioning of undergraduates with ADHD, fewer students with ADHD pursue graduate 
education than do non-diagnosed peers. Nevertheless, given the proportion of adults in 
the general population estimated to have ADHD and the identification of efficacious 
treatments to reduced ADHD symptomatology, it is reasonable to assume that a sub-
population of graduate students with ADHD does exist. Further investigation into this 
sub-population is warranted in order to determine whether or not these students may be 
experiencing similar challenges to those observed among undergraduates with ADHD. 
ADHD and Prescription Stimulant Medication 
Treatment of ADHD symptomatology in university students and other young 
adults is similar to treatment of children with ADHD, with respect to the use of 
prescription stimulant medication.  Although a variety of alternative treatments have been 
explored in managing ADHD symptomatology in children and adults, pharmacological 
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treatment has been identified as most effective treatment protocol in managing the 
disorder in both children and adults. Specifically, psychostimulant medication has been 
found to be the most effective treatment intervention for ADHD, and is the most widely 
used medication by individuals with ADHD. The number of adolescents and college 
students treated with prescription stimulants for ADHD has steadily increased in the past 
decade (Advokat, Lane & Luo, 2010; Kolar, Keller, Golfinopoulos, Cumyn, Syer, & 
Hechtman, 2008; Wilens, Spencer, and Biederman, 1998).  Four stimulant medications 
are FDA-approved for treatment of the disorder: methylphenidate, dextroamphetamine, 
pemoline, and Adderall (Weyandt, 2006).  Stimulant medication is thought to help 
alleviate symptoms of ADHD by increasing arousal of the central nervous system 
through increasing dopamine levels, thus “regulating” the dysfunctional frontro-striatal 
pathway (Weyandt, 2006). Stimulants increase the availability of dopamine in the brain 
by limiting reuptake of dopamine, facilitating neurotransmitter release, and in some 
cases, blocking reuptake of both norepinephrine and dopamine (DuPaul, Weyandt & 
Booster, 2009; Weyandt, 2006).  
  A robust body of research studies supports the utility of stimulant medications to 
treat ADHD in both children and adults.  A 2009 study using fMRI technology found a 
single dose of methylphenidate to stimulate neural function in the fronto-striatal circuit of 
children with ADHD (Rubia, Halari, Cubillo, Brammer & Taylor). Methylphenidate has 
also been observed to effectively suppress activity of the neural network associated with 
task irrelevant mental processes and off-task cognitions in children with ADHD (Peterson 
et al., 2009).  Stimulant medication has likewise been associated with decreased 
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dopaminergic activity in the caudate, as well as associated inattentive behaviors (Volkow, 
Wang & Newcorn, 2007) among children.   
The literature documents benefits that stimulant medication extends to adults with 
ADHD as well, as a substantial body of controlled studies has found stimulants to reduce 
ADHD symptoms in adults with ADHD (Connor, 2006). Qualitative investigations have 
also suggested that stimulants may reduce symptoms and associated impairment in a 
number of areas of functioning, among university students with ADHD (Heiligenstein, 
Johnston, & Nielsen, 1996).  
Because prescription stimulant medication has been cited as a particularly 
effective treatment for managing ADHD symptoms in children, adolescents and adults 
(Adler et al., 2009; Baverstock & Finlay, 2003; Prince, Wilens, Spencer, & Biederman, 
2006; Wilens, Biederman & Spencer, 1998), stimulant medications are widely prescribed 
to manage ADHD symptoms in university students. Previous investigations have 
suggested that the medications reduce impulsivity and hyperactivity, increase attentional 
abilities, and reduce impaired psychological and social functioning among college 
students with ADHD (Advokat, Lane & Luo, 2010; DuPaul et al., 2011; DuPaul et al, 
2009; Heiligenstein et al. 1996; Weyandt & DuPaul, 2006). 
Although prescription stimulants are relatively safe when taken as prescribed, 
they are not without risks and side effects and are classified by the U.S. Food and Drug 
Administration (FDA) as Class II medications because they can be abused or lead to 
dependence (United States Food and Drug Administration, 2011). Still, data also exists to 
support the use of caution when considering stimulant medication to treat ADHD 
symptoms in both children and adults. Prescription stimulant medications have been 
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observed to cause a number of undesirable mental health side effects for individuals who 
take them, including increased anxiety and the onset of novel psychotic symptoms such 
as mania and auditory hallucinations (Curran, Byrappa, & McBride, 2004; Surles, May, 
& Garry, 2002; Murray, 1998; U.S. Food & Drug Administration, 2007). The emergence 
of such symptoms may be particularly problematic in young adults because symptoms of 
organic psychotic disorders such as schizophrenia frequently emerge in late adolescence 
or early adulthood (APA, 2000), making accurate differential diagnosis challenging for 
practitioners.  
Psychostimulant medications have also been found to increase systolic blood 
pressure, diastolic blood pressure, and heart rate, all of which are cardiovascular risk 
factors (Hammerness, Surman, & Chilton, 2011; Stiefel & Besag, 2010). The FDA 
suggests that stimulant products should not be used in patients with serious heart 
problems, or for whom an increase in blood pressure or heart rate would be problematic, 
and that patients treated with stimulant medications should be periodically monitored for 
changes in heart rate and blood pressure (United States Food and Drug Administration, 
2011). Emergency room visits involving prescription stimulant medications have become 
increasingly common in recent years. A report issued by the U.S. Substance Abuse and 
Mental Health Services Administration (SAMHSA, 2013) indicated that, although the 
number of emergency department visits involving stimulant medications did not increase 
significantly for children between 2005 and 2010, visits for adults increased from 13,379 
in 2005 to 31,244 in 2010. Regarding non-medical use of stimulants, the number of 
emergency department visits increased from 5,212 to 15,585 (SAMHSA, 2013). The 
report indicated that other pharmaceutical drugs were also implicated in 45% of visits 
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involving stimulant medications, illicit drugs were implicated in 21% of visits involving 
stimulant medications, and alcohol was implicated in 19% of visits involving prescription 
stimulants. 
Despite the documentation of cardiovascular side effects, however, a recently 
published twenty-year retrospective, population-based, cohort study found no association 
between use of psychostimulant medications and risk of serious cardiovascular events 
among young and middle aged adults (Habel et al., 2011).  Early studies cite lower levels 
of efficacy for stimulants in treating ADHD, as in a 1993 meta-analysis that found 
stimulant medication to be largely ineffective for 25 to 40 percent of children with 
ADHD (Swanson et al., 1993).  These early results stand in stark contrast to the body of 
contemporary research cited here, perhaps because of improvements in medication 
formulas or increased knowledge and understanding of ideal stimulant type, dosage 
levels, etc. by physicians. Higher rates of aversive side effects of ADHD medications 
have also been found when individuals have been diagnosed with a co-morbid disorder or 
disability in addition to ADHD.  For example, lack of symptom improvement has been 
observed in samples of children who have both ADHD and a co-morbid anxiety disorder 
(Pliszka, 1999) or cognitive impairment (Handen, Feldman, Gosling, Breaux & 
McAuliffe, 1991). Additionally, qualitative and survey research supports the assertion 
that some university students with ADHD are ambivalent about their stimulant 
medication protocol, citing undesirable side effects and limited treatment benefits 
(Advokat et al., 2010; Loe & Cuttino, 2008). Nevertheless, having been empirically 
validated as a relatively safe and effective treatment for ADHD symptoms in children and 
adults, stimulant medications are often the first, and sometimes the only, intervention 
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used to ameliorate the impaired behavioral and cognitive and functioning associated with 
the pathology of ADHD in young adults.  
Prevalence and Nature of the Non-Medical Use of Prescription Stimulants 
Recent research has raised concerns that students with ADHD may give or sell 
their prescribed stimulants to their peers, or have reported their medication stolen by 
classmates (Rabiner et al., 2009; Weyandt et al., 2009).  Regardless of the method by 
which students are obtaining the medication, stimulant medication has been reported to 
be accessible on university campuses (McCabe et al., 2005; Rabiner et al., 2009; Sharp & 
Rosen, 2007; Weyandt et al., 2009), and non-medical use of stimulants is a growing 
concern for educators and practitioners.  
 Recent investigations have identified widespread prescription stimulant use 
among undergraduate students (DeSantis et al., 2010; DuPont et al., 2008; Hall et al., 
2005; Judson & Langdon, 2009; Low & Gendaszek, 2002; McCabe et al., 2005; Rabiner 
et al., 2009; Sharp & Rosen, 2007; Weyandt et al., 2009; White et al., 2006). Rates of 
reported past-year non-medical use vary across studies, and range from less than 5% to 
nearly 20% of students (DuPont et al., 2008; Judson & Langdon, 2009). A number of risk 
factors associated with increased use of prescription stimulants have been identified: 
students who are male, Caucasian, involved in Greek life, have a lower GPA, report 
greater “academic strain,” and/or live in the Northeastern United States more likely to 
report non-medical stimulant use (Advokat, Guidry & Martino, 2008; DuPaul et al., 
2009; Dussault & Weyandt, 2013; Ford & Schroeder, 2009; McCabe et al., 2005; White 
et al., 2006). Psychological variables have also been observed to associate with 
prescription stimulant use, and variables associated with non-medical use, including 
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overall psychological distress, depression, anxiety, sensation-seeking, and internal 
restlessness (Dussault & Weyandt, 2013; Peterkin et al., 2011; Rabiner et al., 2009; Teter, 
Falone, Cranford, Boyd & McCabe, 2010; Weyandt et al., 2009).  
 Indeed, non-medical stimulant use is not exclusive to adolescents and college 
students, and has also been observed among professional students and other young adults. 
Young adults appear to use stimulants regardless of educational trajectory, and non-
medical use among non-students has been reported by 4.3% of adults aged 18-25 (Novak 
et al., 2007). Although a growing body of research has focused on non-medical stimulant 
use among undergraduates, the literature has yet to specifically examine use among 
graduate students, a population at risk for non-medical use because of increased stress 
levels and heightened academic demands.  A study including both undergraduate and 
graduate students (Prudhomme et al., 2006) found that 11% of students over the age of 24 
(graduate students comprised 74% of this age group) endorsed non-medical use, along 
with 16.9% of the overall sample. McNiel et al. (2011) found that 12.4% of dental and 
dental hygiene students reported non-medical use of prescription stimulants. Medical 
school students (10.1%; Frick, Frick, Coffman & Dey, 2011) and students enrolled in an 
accelerated doctor of pharmacy program (11.6%; Tuttle, Scheurich & Ranseen, 2010) 
report similar rates of non-medical use. Researchers examining stimulant use among 
medical students posited that non-medical use among post-graduate students may relate 
to observed associations between stimulant use and perfectionism, application to 
competitive programs, and desire for academic success (Low & Gendaszek, 2002; 
McCabe et al., 2005; Teter et al., 2005). 
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Psychological Functioning Among Graduate Students 
The lack of research exploring non-medical prescription stimulant use in the 
graduate population is surprising given the observed association between use and several 
aspects of psychological functioning, including depression (Rabiner et al., 2009b; Teter et 
al., 2010; Weyandt et al., 2009) anxiety (Dussault & Weyandt, 2013; Weyandt et al., 
2009), and stress (Janusis & Weyandt, 2010). Investigations have identified high rates of 
perceived stress among students, associated with poor sleep hygiene, inadequate social 
support, poor emotion regulation, lack of exercise and underdeveloped coping 
mechanisms (McKinzie et al., 2006; Myers et al., 2012; Nelson et al., 2001). Graduate 
students from a variety of programs report elevated levels of stress stemming from: 
academic coursework, research projects, clinical training, performance anxiety, 
institutional demands, lack of experience, time constraints, sleep deprivation, limited free 
time, competitive peer environment, interpersonal relationships and financial strain 
(Badali & Habra, 2003; Levey, 2001; Nelson et al., 2001).   
 A 2009 study by the American Psychological Association's Advisory Committee 
on Colleague Assistance of psychology graduate students found that 70% of participants 
reported having experienced significant stress during the previous year (ACCA, 2009, in 
El-Ghoroury, 2011). Stress levels among graduate students may vary according to the 
nature, pace and duration of the graduate program; students in an accelerated 3-year 
doctoral program reported significantly more stress than a comparison group from a 4-
year program (Frick et al., 2011).  Ultimately, stress may manifest in internalizing 
disorders, and anxiety and depression have been observed to be highly prevalent among 
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graduate, law, and medical students (Aktekin et al., 2001; Dammeyer & Nunez, 1999; 
Dyrbye et al., 2006; Eisenberg et al., 2010; Helmers et al., 1997).   
Academic Self-Efficacy Among University Students 
 A student’s perceived level of capability to meet task demands may also 
influence their academic and psychological functioning, and academic self-efficacy has 
been associated with both academic functioning and psychological adjustment in 
undergraduate and graduate students (Chemers, Hu, & Garcia, 2001; Hackett, Betz, 
Casas, & Rocha-Singh, 1992; Multon, Brown, & Lent, 1991; Pajares, 1996; Majer, 2009; 
Zajacova, Lynch & Espenshade, 2005). Self-efficacy, a concept introduced by Bandura 
(1986), references one’s self-evaluation of competence to successfully reach one or more 
desired outcomes. Academic self efficacy refers to a student’s self-perceptions 
concerning their abilities to achieve specific academic goals.  A 1991 meta-analysis of 
research on the correlation between self-efficacy and academic success (Multon, Brown, 
& Lent) found that self-efficacy was positively, significantly, and reliably correlated with 
academic success and academic performance in university students.  A 2001 study 
observed that academic self-efficacy was directly correlated not only with levels of 
academic achievement, but also with psycho-social adjustment among undergraduate 
students, and academic self-efficacy was observed to mediate effects for academic 
expectations, academic performance, stress, health, overall satisfaction, and commitment 
to remain enrolled in school (Chemers, Hu, & Garcia).  Zajacova, Lynch, & Espenshade 
(2005) investigated the relationship between the academic self-efficacy, stress levels, and 
academic success of undergraduate students, ultimately finding that academic self-
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efficacy was more predictive of academic success (as measured by overall grade point 
average and number of accumulated credits) than stress.  
These findings have been replicated in mixed-gender and ethnically diverse 
samples as well. Majer (2009) explored academic-self efficacy in an ethnically diverse 
sample of community college students, finding that baseline rates of self-efficacy were 
predictive of academic success (as measures by overall grade point average) one year into 
the academic program. Hackett, Betz, Casas, & Rocha-Singh (1992) investigated the 
relationships between academic self-efficacy, vocational interests, outcome expectations, 
academic ability, perceived stress, support, coping, and academic achievement, finding 
that self-efficacy for academic milestones was the strongest predictor of college academic 
achievement for a sample of undergraduate students enrolled in engineering programs.  
 While the majority of investigations concerning academic self-efficacy focus on 
undergraduate university students, a 1998 study (Santiago & Einarson) was conducted 
focusing specifically on the academic self-efficacy of graduate students. Investigators 
used data from the Graduate Experience Project to examine possible predictors of 
academic self-confidence, academic self-efficacy, and outcome expectations of science 
graduate students.  Santiago and Einarson hoped to determine whether gender or ethnic 
differences among graduate students may be associated with differences in academic self-
confidence and self-efficacy. Further, investigators hoped to discover whether student 
background characteristics would predict academic self-confidence or academic self-
efficacy, with the ultimate goal of better identifying subsets of students at risk for 
attrition in order to inform preventative programmatic supports. Results suggested that 
neither gender nor ethnicity were predictive of academic self-efficacy at the time students 
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entered the program. Results provided some insight into factors that appeared to predict 
academic self efficacy among graduate students, however, including: student perceptions 
of academic preparedness, status-related disadvantages, and expectations about 
faculty/student interactions.  
A more recent investigation (You & Chen, 2012) considered the relationship 
between academic self-efficacy, academic stress, optimism and suicidal ideation in a 
population of Chinese doctoral students.  Results suggested that students with lower 
levels of academic self-efficacy reported higher levels of academic stress and greater 
likelihood of suicidal ideation. Academic self-efficacy was also found to predict student 
optimism, and both factors acted as mediators between academic stress and suicidal 
ideation. In another recent study examining the relationship between academic self-
efficacy and psychological functioning among graduate students, Ghaderi (2010) 
examined the relationship between self-efficacy and anxiety in a sample of masters-level 
and doctoral-level students. Previous investigations have found self-efficacy to correlate 
with symptoms of impaired psychological functioning among children and adults, 
including depression (Bandura, Pastorelli, Barbaranelli, & Caprara, 1999; Lavasani, 
Khezriazar, Amani, & Malahmadi, 2011) anxiety (Lavasani, Khezriazar, Amani, & 
Malahmadi, 2011; Muris, 2002), and stress (Chemers, Hu, & Garcia, 2001; Lavasani, 
Khezriazar, Amani, & Malahmadi, 2011). Lavasani and colleagues (2011) specifically 
explored the relationship between academic self-efficacy, academic goals, and levels of 
depression, anxiety and stress among undergraduate students, finding that academic self-
efficacy was predictive of stress, anxiety and depression, irrespective of academic field of 
study.  
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Ghaderi (2010) collected data from 80 male graduate students and 80 female 
graduate students at an Indian university. Because the study also considered possible 
effects for country of origin, as well as gender, half of the students were of Indian 
descent, and half were of Iranian descent. All students were enrolled on a full-time basis 
in masters or doctoral-level programs, and students from a variety of academic 
departments were sought to participate. While no gender effect emerged, results indicated 
that Indian students endorsed greater anxiety than their Iranian counterparts, that masters-
level students endorsed higher levels of anxiety than doctoral-level students. Notably, 
results also indicated that students with lower expressed academic self efficacy reported 
significantly higher levels of anxiety.  
Psychological and Academic Functioning and Risk for Non-Medical Stimulant Use 
A number of psychological and academic variables have been observed to 
associate with the non-medical use of prescription stimulants. Relevant psychological 
variables include depression (Huang, Dawson, Stinson, Hasin, Ruan, Saha, et al., 2006; 
Poulin, 2007; Teter, Falone, Cranford, Boyd & McCabe, 2010), anxiety (Dussault & 
Weyandt, 2013; Weyandt et al., 2009), stress (Dussault & Weyandt, 2013; Peterkin, 
Crone, Sheridan & Wise, 2011), and internal restlessness (Dussault & Weyandt, 2013, 
Weyandt et al., 2009).  In perhaps the largest, most well-designed study considering the 
non-medical use of prescription stimulants, Huang et al. (2006) analyzed data derived 
from a large (N = 43,093), representative sample of adults in the United States that was 
related to the non-medical use of a variety of prescription medications. Greater non-
medical use of prescription stimulants (specifically, amphetamines) was reported by 4.7% 
of participants, and higher rates of abuse and dependence of these medications were 
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reported than any other category of medication (2%). Results indicated that individuals 
with previously diagnosed Axis I and Axis II disorders were more likely to report the 
non-medical use of prescription drugs, and non-medical use of amphetamines was 
significantly associated with depressive symptoms. The non-medical use of prescription 
stimulants has also been found to associate with elevated levels of reported depression 
among adolescents (Poulin, 2007). The non-medical use rates of methylphenidate and 
amphetamine use were 6.6% and 8.7%, and use was associated with positive screening 
results for ADHD symptomatology and depression symptomatology, among participants. 
Poulin suggested that that the non-medical use of prescription stimulants may indicate the 
presence of undiagnosed pathology in adolescent students who use the medications. Teter 
et al. (2010) investigated the relationship between depressed mood and the non-medical 
use of prescription stimulants among undergraduate university students and found that 
frequent users of non-medical use of prescription stimulant medications and users who 
endorsed non-oral routes of administration indicated significantly higher levels of 
depressive symptomatology. Indeed, students who reported frequent non-medical use of 
prescription stimulants were twice as likely as peers to report significantly depressed 
mood over the previous month.  
Weyandt et al. (2009) investigated the relationship between the non-medical use 
of prescription stimulants by university students and various aspects of psychological 
functioning. Results indicated that non-medical use of prescription stimulants was 
correlated with overall psychological distress, as measured by total score on the Brief 
Symptom Inventory. Non-medical use of prescription stimulants was also correlated with 
self-reported symptoms relating to Somatization, Obsessive-Compulsive, Interpersonal 
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Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and 
Psychoticism (Weyandt et al., 2009).  The relationship between the non-medical use of 
prescription stimulant medications and self-reported anxiety among undergraduate 
university students has also been demonstrated in more recent research. In 2013, Dussault 
& Weyandt investigated the relationship between the non-medical use of prescription 
stimulant medications and self-reported levels of depression, anxiety and stress. While 
associations between reported level of depression and non-medical stimulant use were 
not observed, the non-medical use of prescription stimulants was positively associated 
with self-reported levels of anxiety, as well as stress. Self-reported internal restlessness 
has also been positively associated with the nonmedical use of prescription stimulants 
among undergraduate university students (Dussault & Weyandt, 2013; Weyandt et al., 
2009). Specifically, Dussault & Weyandt observed increased levels of self-reported 
internal restlessness and internal impulsivity to correlate with self-report of non-medical 
prescription stimulant use, while Weyandt et al. noted a significant positive correlation 
between self-reported non-medical use and self-reported internal distractibility, internal 
impulsivity, and internal disorganization.  
Many undergraduate students report engaging in the non-medical use of 
stimulants during academic activities, such as studying, test-taking and writing papers 
(DeSantis, Noar & Webb, 2010; DuPont et al., 2008; Rabiner et al., 2009; Sharp & 
Rosen, 2007; Weyandt et al., 2009), suggesting that university students reporting 
concerns associated with academic functioning may also be at increased risk for non-
medical use of stimulant medication related to academic demands.  In Peterkin et al.’s 
(2011) investigation of non-medical stimulant use among university undergraduates, the 
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most common reason participants provided to justify their use was “to improve study 
skills,” with 89% of students who reported non-medical use endorsing that motivation.  
When motivations for non-medical use of prescription stimulants were classified as either 
academic or non-academic in nature, a significant majority of participants (87%) 
endorsed academic motivations. DeSantis, Noar & Webb’s (2010) investigation of non-
medical stimulant use among fraternity members also indicated that most users reported 
academic factors as a motivator for use, with 74% of participants indicating that they 
used the medications to stay awake while studying, 59% indicating that they used the 
medications to improve concentration while studying, and 30% indicating that they use 
the medications to help them memorize course material.  
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Statement of Purpose 
 Although a substantial number of studies have been conducted examining 
stimulant use among undergraduates, the literature has yet to specifically assess non-
medical use among a diverse cross-section of graduate students, a population which has 
previously reported elevated levels of stress, anxiety and depression, factors which have 
been associated with non-medical use among undergraduates. To date, no studies have 
explored the relationship between academic self-efficacy, psychological variables, and 
internal restlessness with non-medical use of these medications among graduate students. 
The purpose of the present study is to examine the prevalence and nature of non-medical 
prescription use among graduate students, and to explore the relationship between such 
use with academic and psychological variables.  It is suggested that results of such an 
investigation could potentially be used to identify sub-populations of graduate students 
who may be at risk for non-medical use of stimulant medication, and to inform 
prevention and intervention strategies designed to address non-medical use among 
graduate students. For the purposes of the current investigation, the term “non-medical 
use” was used to describe use of prescription stimulants by individuals other than those 
for whom the medication was prescribed.   
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Research Hypotheses 
 It was hypothesized that non-medical use of stimulants would be reported by 
graduate students at rates similar to those reported by professional and 
medical students (8% or greater reporting non-medical use over the past 12 
months), as reported on the Self-Reported Prescription Stimulant Use and 
Perception of Prevalence of Prescription Stimulant Use Among Peers 
subscales of the Stimulant Survey Questionnaire (SSQ; Weyandt et al., 2009).   
 Further, it was hypothesized that graduate students who reported non-medical 
use of stimulants would report greater perceived self-knowledge regarding 
stimulants, and regard stimulant use as being safer than graduate students who 
do not use stimulants, as measured by the Perception of Safety of Stimulants 
subscale of the SSQ (Weyandt et al., 2009).   
 It was also hypothesized that graduate students who reported non-medical use 
of stimulants would endorse lower academic self-efficacy ratings than peers 
who did not report non-medical use of stimulants, as measured by the 
Academic Self-Efficacy Scale (ASES; Santiago & Einarson, 1998).  
 Additionally, it was hypothesized that graduate students who report non-
medical use of stimulants would endorse higher ratings of depression, anxiety 
and stress than peers who did not report non-medical use of stimulants, as 
measured by the Depression, Anxiety Stress Scales-21 (Lovibond & 
Lovibond, 1995).  
 Finally, it was hypothesized that graduate students who report non-medical 
use of stimulants would endorse higher ratings of internal restlessness than 
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peers who did not report non-medical stimulant use, as measured by total and 
subscale scores on the Internal Restlessness Scale (Weyandt et al., 2003).  
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Method 
Participants 
 Participants were 807 male and female graduate students from a variety of 
masters-level, specialist-level and doctoral-level graduate programs in the United States. 
Participants were recruited from five public universities located in regions of the United 
States: Northeast, Southeast, Central-Midwest, Northwest, and Southwest. Universities 
from various regions of the nation were included in an effort to obtain a diverse, 
geographically representative sample of participants. Each university identified for 
inclusion was previously the site of at least one investigation of non-medical prescription 
stimulant use among students at the undergraduate level (University of Rhode Island, 
Weyandt et al., 2009; University of Michigan, Teter et al., 2010; University of Central 
Florida, Ford & Schroeder, 2009; San Diego State University, Shillington, Reed, Lange, 
Clapp & Henry, 2006; and the University of Washington, Dussault & Weyandt, 2013).   
A total of 854 students completed the survey measures online. Of this total, 33 
students (3.7% of total respondents) reported currently taking stimulant medication as 
prescribed by a health care provider, and were excluded from the sample. An additional 
14 students provided consent but did not complete sufficient items for analysis, and were 
eliminated from the sample. A power analysis performed prior to data collected 
suggested that with expected effect size being small (f = .1), a series of two-group 
univariate ANOVAs would require a minimum of 788 participants.  A power analysis 
was also conducted based on multiple regression with alpha level set at .05, and power 
set at .80. With expected effect size being small (f2 = .02), a minimum of 688 participants 
was suggested.  As such, the final sample size of the present study (N = 807) was 
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calculated to have adequate power for detection of expected effect sizes in the variables 
of interest given the anticipated analyses. The sample was also determined to have met 
recommended requirements of ratio of cases to independent variables (Tabachnick & 
Fidell, 2007). 
The five universities were not equally represented within the sample, with the 
largest proportion of participants coming from the university located in the Northeast 
(37%). Twenty-four percent of participants were enrolled at a university in the Midwest, 
17.8% at a university in the Southeast, 14.1% at a university in the Southwest, and 4.5% 
at a university in the Northwest. A small number of participants, comprising 1.8% of the 
total sample, reported that they were enrolled at a university other than the five 
universities targeted by the researcher. Because no comparisons were made between 
universities, the disproportionate representation of universities/geographic regions did not 
affect analyses. A majority of participants were female (72.1%), with 26% of participants 
identifying as being male and 1.9% indicating that they preferred not to disclose their 
gender. A majority of participants (65.8%) reported being between 22 and 29 years of 
age. A majority of participants (76.6%) identified their ethnicity as being 
White/European American; while 8.6% of participants self-identified as Latino/Hispanic 
American, 6.3% as Asian/Asian American, 2.2% as Multiethnic, 1.9% as Black/African 
American, and .4% as Native American/American Indian.  Additional demographic 
information pertaining to gender, age, and ethnicity at each university is provided in 
Table 1.  
Participants reported being enrolled in master’s-level (43.5%), specialist-level 
(1.9%), and doctoral-level (53.9%) degree programs. Students reported various fields of 
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study, including: Computer Science/Information Technology, Education, Engineering, 
Fine Arts & Design, Health Industry, Public Services, Humanities, Medical and Health 
Professions, Mental Health Professions, Biomedical Sciences, Environmental Sciences, 
Natural/Physical Sciences, and Social Sciences. Graduate students from Social Sciences 
programs were most heavily represented within the sample, comprising 26.8% of the total 
sample. Additional demographic information pertaining to academic enrollment of 
participants is provided in Table 2.  
Demographic information was also collected from participants pertaining to 
mental and physical health. Participants endorsed a variety of previous diagnoses related 
to impaired psychological functioning, including Attention-Deficit Hyperactivity 
Disorder, Anxiety, Depression, Bi-Polar Depression, Eating Disorder, and Specific 
Learning Disability.  Because participation was anonymous, previous diagnoses could not 
be verified. A small number of participants reported currently having a major physical 
disability. Students who endorsed a physical or mental disability were asked to indicate 
whether they had registered with the disability support services on their campus; 1.9% of 
participants reported having done so. Additional demographic information pertaining to 
the reported history of physical and mental disabilities among study participants is 
provided in Table 3. 
Measures 
Demographic Information Form 
 Demographic information was obtained via a short self-report questionnaire 
developed by the investigator (Appendix E).  The form requested basic demographic 
information, including participant age, gender, ethnicity, university, and degree program. 
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Students were also asked to indicate whether or not they have been diagnosed with 
ADHD, and whether they possessed a current medical prescription for stimulant 
medication. Graduate students who report having ADHD were not excluded from 
participation; however, those endorsing a current prescription for stimulant medication 
were excluded.  
Stimulant Survey Questionnaire (SSQ)  
Forty items comprise the SSQ (Weyandt et al., 2009), which was designed to 
assess the medical and non-medical use of prescription stimulant medications among 
college students.  The SSQ also examines attitudes toward and knowledge about 
prescription stimulant use among other students). The majority of the survey (30 items) is 
formatted as a series of statements to which participants endorse responses on a 5-point 
Likert scale.  For 20 of those items, the possible values endorsed range from 1 (“never”) 
to 5 (“always”), and for the remaining ten items, a value of 1 signifies that the respondent 
“strongly disagree[s]” with the statement, and a value of 5 indicates that the respondent 
“strongly agree[s].” The final ten items are presented in a dichotomous forced-choice 
format. The SSQ generates a total score, and items have been observed to load on four 
factors: (1) Self-reported prescription stimulant use, (2) Perception of prevalence of 
prescription stimulant use among peers, (3) Knowledge of atypical stimulant use among 
peers, and (4) Perception of safety of stimulants (Weyandt et al., 2009).  
 Preliminary analysis found the SSQ to have adequate internal consistency (α = 
.85; Weyandt et al., 2009). A principal-axis factor analysis indicated that the four factors 
accounted for 51.11% of the total variance. Internal consistency varied across the factors: 
self-reported prescription stimulant use (α = .92), perception of prevalence of prescription 
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stimulant use among peers (α = .43), knowledge of atypical stimulant use among peers (α 
= .61), and perception of safety of stimulants (α = .61; Weyandt et al., 2009). Internal 
consistency of the measure and factors has been observed to be adequate in subsequent 
investigations (Dussault & Weyandt, 2013; Janusis & Weyandt, 2010), with rates of 
internal consistency on one factor (the perception of safety of stimulants) comparatively 
low (α = .62), but stable across studies. In the present study, internal consistency varied 
somewhat across factors but was adequate: self-reported prescription stimulant use (α = 
.87), perception of prevalence of prescription stimulant use among peers (α = .89), 
knowledge of atypical stimulant use among peers (α = .63), and perception of safety of 
stimulants (α = .69). An excerpted copy of the SSQ (Appendix F) is included. For the 
present study, the total and subscale scores of the SSQ each served as dependent 
variables for analyses. 
The Internal Restlessness Scale (IRS)  
 The IRS (Weyandt et al., 2003) is a self-report instrument that attempts to 
measure mental restlessness among college students. Twenty-four statements related to 
internal restlessness comprise the scale, for which respondents must endorse a Likert-
style response.  Responses indicate for what proportion of the time each statement is true 
for participants, and options range from a value of 1 (“none of the time”) to 7 (“all of the 
time”). The IRS also generates a total score, and items have been observed to load on 
four factors: Internal distractibility, internal impulsivity, internal restlessness, and 
internal disorganization (Weyandt et al., 2003).  
 Previous studies utilizing the IRS have demonstrated adequate test– retest 
reliability, construct validity, and concurrent validity of the IRS based on correlations 
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with self-report instruments frequently used to assess ADHD in young adults (Weyandt et 
al., 2003; Weyandt, Hays, & Schepman, 2005). More recent studies with undergraduate 
students have raised concerns about the construct validity of the scale given the relatively 
low internal consistency observed in two of the proposed factors (internal impulsivity (α 
= .66); internal disorganization (α = .51)), but overall internal consistency for web 
administration of the IRS is commensurate with that observed in traditional 
administration (Dussault & Weyandt, 2013). An excerpted copy of the IRS (Appendix G) 
is included. Internal consistency for the present sample was as follows: internal 
distractibility (α = .89); internal restlessness (α = .79); internal impulsivity (α = .88); 
internal disorganization (α = .77). For the present study, the total and subscale scores of 
the IRS each served as dependent variables for analyses. 
The Depression Anxiety Stress Scale -21 (DASS-21)  
 The DASS-21 (Lovibond & Lovibond, 1995) is a self-report measure designed to 
assess levels of anxiety, depression and perceived stress among adults. The scale asks 
respondents to use a Likert-style reply format to indicate how often a series of statements 
have applied to them during the preceding seven days.  Response options on the 4-point 
scale include values from 0 (“did not apply to me at all”) to 3 (“applied to me very 
much/most of the time”; Lovibond & Lovibond, 1995).  
 Previous research has found internal consistency to be quite high on each of the 
three subscales: depression (α = .91; α = .97), anxiety (α = .81; α = .92), stress (α = .88; α 
= .92; Antony, Bieling, Cox, Enns, & Swinson, 1998; Lovibond & Lovibond, 1995). The 
present study demonstrated adequate internal consistency on each of the three subscales 
as well: depression (α = .89), anxiety (α = .76), stress (α = .88; α = .87). The DASS-21 
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has also demonstrated high rates of concurrent validity when examined against lengthier, 
well-established measures including the Beck Depression and Anxiety Inventories 
(Antony et al., 1998). A recent investigation of the psychometric properties of the DASS-
21 scales when administered online noted that while the combination of all items may not 
be an appropriate measure of overall psychological distress, the three subscales 
demonstrated adequate internal consistency reliability, unidimensionality and freedom 
from differential item functioning for sex, age and mode of administration when 
considered independently (Shea, Tennant & Pallant, 2009). An excerpted copy of the 
DASS-21 (Appendix H) is included.  For the present study, the Depression, Anxiety, and 
Stress subscale scores of the DASS-21 each served as dependent variables for analyses. 
Academic Self-Efficacy Scale  
 The Academic Self-Efficacy Scale (ASES; Santiago & Einarson, 1998) is a 10- 
item, self-report measure designed to assess graduate students’ perception of their ability 
to meet a variety of academic demands. The scale asks respondents to use a Likert-style 
reply format to indicate how confident they are in their abilities to complete a number of 
tasks, endorsing a belief that that are “very,” “somewhat,” or “not at all confident” in 
their abilities to complete activities including: completing their degree in a timely 
manner, handle course work, and conduct research. Total possible scores range from 0, 
indicating a very low degree of self-efficacy, to 20, indicating a very high degree of self-
efficacy. Previous investigations have noted a high degree of internal consistency across 
items (r = .80; Santiago & Einarson, 1998), and internal consistency calculated on the 
present sample was adequate (α = .79).  An excerpted copy of the ASES (Appendix I) is 
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included. For the present study, the total score of the ASES served as a dependent 
variable for analyses. 
Procedure 
 Following approval of the study by the Institutional Review Board at the 
University of Rhode Island, program directors and department chairs on each of the five 
campuses were contacted via email. Contacts were provided with a synopsis of the study 
as well as a request for facilitation of the solicitation of participation from graduate 
students [Appendix A]. In the absence of a reply following the initial email contact, two 
reminder emails were sent at ten-day intervals. Students from all master’s-level, 
specialist-level and doctoral-level graduate programs were eligible to participate, in an 
effort to obtain a diverse and representative sample of participants [Appendix B]. A link 
was included in the email which enabled students to access the informed consent forms, 
all associated survey measures, and debriefing materials. Interested department chairs and 
program administrators were asked to distribute the email containing the link to students 
who may be eligible and willing to participate. Participants were instructed to enter a 
secure and encrypted screen hosted via the website for commercial research platform 
SurveyMonkey and prompted to read the informed consent document.  After confirming 
that they had read the document, participants were encouraged to print the informed 
consent form for future reference.  Participants who provided consent were presented 
with electronic versions of five measures: a demographic survey designed by the 
researcher, the Stimulant Survey Questionnaire (Weyandt et al., 2009), the Internal 
Restlessness Scale (Weyandt et al., 2003), the Academic Self-Efficacy Scale (Santiago & 
Einarson, 1998), and the Depression Anxiety Stress Scale -21 (Lovibond & Lovibond, 
 36 
1995). After completing all measures, participants were provided with a virtual 
debriefing of the study, including specific information about mental health support 
services available on campus and information about how to contact the researchers 
directly if desired (debriefing materials included in Appendix C). Data were collected in 
several waves between November 2012 and March 2013.  
 Graduate students who logged on to the study’s website were required to 
document having viewed the informed consent form (Appendix D) before they were 
permitted to complete the measures. Students who did not provide consent were excluded 
from the study. Unfortunately, data could not be compiled from the research platform on 
how many potential participates accessed the link but failed to consent.   The informed 
consent form contained contact information for the primary investigator, and indicated 
that if participants desired further information before choosing to participate in the study, 
contact could be established via email or telephone. This form detailed the requirements 
and responsibilities of participating in the study, including a basic description of the 
research project (timeline, potential for harm, confidentiality, etc.). Participants were 
made aware that they had the opportunity to discontinue participation in the assessment at 
any time without penalty.  Participants were encouraged to print a copy of the form for 
future reference in the case of undesired effects associated with participation or a desire 
to access a copy of the final report.  
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Results 
The independent variable of interest in this study was reported non-medical use of 
prescription stimulants, as assessed via SSQ Factor 1: Self-Reported Use. Dependent 
variables included: perception of stimulant safety (as assessed via the Perception of 
Safety of Stimulants factor of the SSQ, Weyandt et al.,2009); reported internal 
restlessness (as assessed via total score and the Internal Distractibility, Internal 
Impulsivity, Internal Restlessness, and Internal Disorganization factor scores of the IRS, 
Weyandt et al., 2003); reported levels of anxiety, depression and stress (as assessed via 
the Anxiety, Depression, and Stress factor scores of the DASS-21, Lovibond & 
Lovibond, 1995); and academic self-efficacy (as assessed via the total score of the ASES, 
Santiago & Einarson, 1998).   
 Exploratory descriptive analyses were conducted on a number of demographic 
characteristics, including categorical variables pertaining to both academic (e.g. program 
focus, terminal degree) and non-academic characteristics (e.g. gender, age, ethnicity). 
Prior to statistical analysis, all responses to the Demographic Questionnaire, the DASS-
21, the SSQ, the IRS, and the ASES were numerically coded and entered into SPSS 21.0.  
Data accuracy was checked using preliminary descriptive analyses (e.g. frequency 
distributions) and spot-checks. Preliminary assumption testing was conducted in 
accordance with the guidelines advanced by Tabachnick & Fidell (2007). Means, 
standard deviations, and internal consistencies of the SSQ, DASS-21, IRS, and ASES 
were calculated, and are included in Table 4. Correlational analyses were performed to 
assess the relationships between the four measures, and are included in Tables 5-7.  
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Descriptive Statistics 
The demographics of the sample were compared with university enrollment data 
for each of the five universities gathered via the Common Data Set Initiative (The 
College Board, Peterson's, and U.S. News & World Report: www.commondata.org). 
While the sample was consistent with the universities’ overall graduate student 
populations in terms of ethnicity, participants in the present sample were 
disproportionately female. Female participants comprised 72.1% of the total sample, 
whereas female students comprised 56% of full-time graduate students enrolled at the 
five universities during the 2011-2012 academic year. A majority of participants (65.8%) 
reported being between 22 and 29 years of age and White/European American (76.6%). 
Participants reported being enrolled in master’s-level (43.5%), specialist-level (1.9%), 
and doctoral-level (53.9%) degree programs. Participants endorsed a variety of previous 
diagnoses related to impaired psychological functioning, including Attention-Deficit 
Hyperactivity Disorder (9.3%), Anxiety (20.1%), Depression (21.9%), Bi-Polar 
Depression (2.2%), Eating Disorder (3.0%), and Specific Learning Disability (3.7%). 
These prevalence rates are similar to lifetime prevalence rates observed by Kessler, 
Berglund, Demler, Jin, & Walters (2005), who found that, over the course of the lifetime, 
8.1% of individuals will be diagnosed with Attention-Deficit Hyperactivity Disorder, 
28.8% will be diagnosed with an Anxiety Disorder, and 3.9% with Bi-Polar Depression. 
A small number of participants (1.9%) reported currently having a major physical 
disability. Additional descriptive statistics pertaining to the demographics of the sample 
can be found in Tables 1, 2, and 3. 
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Preliminary Data Analysis 
 Hypotheses were tested using a series of univariate Analyses of Variance 
(ANOVA) and standard multiple regression analyses. Preliminary assumption testing was 
conducted in accordance with the guidelines advanced by Tabachnick & Fidell (2007) 
with regard to: unequal sample sizes, missing data, normality, linearity, outliers, 
homogeneity of variance, homogeneity of regression, ratio of cases to independent 
variables, normality, linearity, homoscedasticity, outliers, multi-collinearity, and 
singularity. Assumptions related to unequal sample sizes were of primary concern, given 
the fact the group failing to endorse previous non-medical use of prescription stimulants 
was far larger than the group reporting non-medical use of stimulants. In order to 
determine whether the disparate sample sizes would result in violations regarding 
homogeneity of variance or equality of means assumptions, Levene, Brown-Forsythe, 
and Welch statistics were calculated prior to analyses. Despite the significant disparity in 
sample sizes, results indicated that assumptions for homogeneity of variances and 
equality of means were met, and no further transformations or parametric modifications 
were required. Missing data ranged between .3% and 1.8%, well below the 5% level 
listed as indicative of concern suggested by Tabachnick & Fidell (2007).  Violations of 
assumptions regarding outliers were noted, and data was adjusted per the re-coding 
technique (e.g. coded as one unit higher than the highest non-outlier value) suggested by 
Tabachnick & Fiddell (2007). The sample size (N = 807) was significantly greater than 
that required to meet the ratio of cases-to-independent variables assumption (N = 130). 
Skewness and kurtosis fell within suggested limits (Tabachnick & Fidell, 2007). 
Preliminary correlational analyses indicated that none of the measures were highly 
 40 
correlated (r ≥ .90), and Tolerance and VIF(variance inflation factor) statistics generated 
by the SPSS program also indicated that the sample was robust to assumptions of 
multicollinearity and singularity. 
Graduate Students and the Non-Medical Use of Prescription Stimulant Medication 
To investigate Hypothesis 1, that non-medical use of stimulants would be reported 
among graduate students at rates similar to those reported by professional and medical 
students (8% or greater reporting non-medical use over the past 12 months), descriptive 
statistics calculations were performed on specific items of the demographic 
questionnaire, the Self-Reported Prescription Stimulant Use subscale of the SSQ, and the 
Perception of Prevalence of Prescription Stimulant Use Among Peers subscale of the 
SSQ.  
A notable proportion of participants (17.5% of the total sample) reported having 
previously used prescription stimulants for non-medical purposes. Overall, 5.9% of 
participants reported non-medical use of prescription stimulant use within the past year.  
Items from the Stimulant Survey Questionnaire provide some insight into the nature of 
and motivations for the non-medical use of prescription stimulants reported by students. 
Many of the most frequently reported motivations for use related to academic activities. 
Among students who endorsed past non-medical use of stimulant medication, the most 
frequently reported motivation for use was “to perform better in my schoolwork,” which 
was endorsed by 16.2% of participants. 10.7% of participants reported having used 
stimulants “to focus better in class,” with nearly as many (10.0%) endorsing having used 
the medication “to perform better on tests.”  
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Not all reported use was related to academic activities, however. The second most 
frequently-reported motivation for use was “to feel more energetic,” which was endorsed 
by 12.3% of participants. Substantial proportions of students reported having used 
prescription stimulants “with alcohol” (10.7%), “at parties” (8.9%), “to help [them] 
socialize better” (7.4%), and “to get high” (7.8%). 
Participant data gathered from SSQ responses also provided insight into student 
behaviors and beliefs regarding stimulant use and peers. More than a quarter of students 
(27.9%) reported being offered prescription stimulant medication by other students, and 
4.5% reported having purchased the medications from peers. Participants indicated a 
belief that peers were engaging in the non-medical use of stimulants to accomplish 
academic tasks. Academic activities were the most frequently cited perceived motivation 
for the non-medical use of stimulants by peers. Over a third of participants (36%) 
reported knowing other students who use the medications “during tests,” with even 
higher numbers for the use of medications by peers “while studying” (43.8%) and 
“during finals week” (44.0%). Perceived social use among peers was also reported, with 
about 1 in 5 participants indicating that they knew students who use prescription 
stimulants “at parties” (20.4%), “with alcohol” (22.1%), and “with other drugs” (18.9%). 
Prescription stimulant medications appear quite accessible on campus, and 
perceived as relatively safe among students, as nearly 1 in 4 participants (24.9%) 
indicated that they “agree” or “strongly agree” that “using prescription stimulants 
occasionally is harmless,” and 15.2% of participants indicated a belief that the 
medications are “easy to get on this campus.” Still, not all students are comfortable with 
the level of prescription stimulant use among peers: 23.3% of students agreed with the 
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statement that “prescription stimulant use on this campus is a problem.” About a third of 
students indicated that they feel “knowledgeable about prescription stimulants” (30.5%) 
and about “the side effects of prescription stimulants” (32.7%). Additional information 
pertaining to the prevalence nature of self-reported stimulant use among participants, 
participant attitudes toward the non-medical use of stimulant medication, and perceptions 
of peer use of stimulants are included in Tables 8, 9, and 10, respectively.   
 For the purposes of further analysis, participants were assigned to groups based 
on endorsement of non-medical prescription stimulant use on the demographic 
questionnaire. A series of univariate ANOVAs was conducted on the two groups of 
participants: those who endorsed having used prescriptions stimulants without a 
prescription previously and those who did not.  A series of ANOVAs was determined to 
be a more appropriate analytic method than a single MANOVA in recognition of the fact 
that several of the dependent variables were conceptually independent (Huberty & 
Morris, 1989). Means, standard deviations, effect sizes and F statistics for all ANOVAs 
are included in Table 11.  
To investigate Hypothesis 2, that graduate students who endorse greater non-
medical prescription stimulant use would report greater perceived self-knowledge 
regarding stimulants and regard stimulant use as being safer than graduate students who 
do not use stimulants, a one-way ANOVA was conducted, with the dependent variable 
being the Perception of Safety of Stimulants subscale of the SSQ.  In support of 
Hypothesis 2, ANOVA results revealed a small but significant group effect for perception 
of safety, as students who reported a history of non-medical prescription stimulant use 
endorsed prescription stimulants as being safer than peers who did not report previous 
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non-medical use. Results were significant at a statistical significance level of .01: F (1, 
799) = 15.197, p < .001, η² = .019.  
Academic Self-Efficacy and the Non-Medical Use of Prescription Stimulant 
Medication  
To investigate Hypothesis 3, that graduate students who endorse non-medical 
prescription stimulant use would report lower academic self-efficacy ratings compared to 
those who do not, a univariate ANOVA was conducted with the total score generated by 
the ASES as a dependent variable. ANOVA results initially revealed a small but 
significant group effect for academic self-efficacy. Although the results were significant 
at the .05 level, they did not reach the level of statistical significance required at the .01 
level: F (1, 799) = 3.926, p < .048, η² = .005. In contrast to Hypothesis 3, this finding 
suggests that students who endorsed previous non-medical use of prescription stimulants 
did not report lower levels of overall academic self-efficacy than peers who did not report 
previous non-medical use. 
Depression, Anxiety, and Stress and the Non-Medical Use of Prescription Stimulant 
Medication 
Hypothesis 4, that graduate students who endorse non-medical prescription 
stimulant use would report higher ratings of depression, anxiety and stress, was tested via 
a series of univariate ANOVAs, with the dependent variables of interest being the 
Depression, Anxiety, and Stress subscales of the DASS-21.  
Regarding self-reported depressive symptomatology, ANOVA results failed to 
reveal a significant group effect for self-reported depression, as measured by the 
Depression subscale of the DASS-21. Results were not significant at the .05 or .01 level: 
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F (1, 799) = 3.221, p = .073, η² = .004. This finding suggests that, in contrast to the 
hypothesis, students who endorsed previous non-medical use of prescription stimulants 
did not report higher levels of depressive symptomatology than peers who did not report 
previous non-medical use. 
Regarding self-reported anxiety symptomatology, ANOVA results revealed a 
small but significant group effect for self-reported anxiety, as measured by the Anxiety 
subscale of the DASS-21. Results were significant at the .01 level: F (1, 799) = 12.44, p 
< .001, η² = .015, suggesting that, students who endorsed previous non-medical use of 
prescription stimulants reported higher levels of anxiety symptomatology than peers who 
did not report previous non-medical use. 
Regarding self-reported levels of stress, ANOVA results revealed a small but 
significant group effect for self-reported stress level, as measured by the Stress subscale 
of the DASS-21. Results were significant at the .01 level: F (1,799) = 17.75, p < .001, η² 
= .022, suggesting that students who endorsed previous non-medical use of prescription 
stimulants reported experiencing higher levels of stress than peers who did not report 
previous non-medical use. 
Internal Restlessness and the Non-Medical Use of Prescription Stimulant 
Medication 
To investigate Hypothesis 5, that graduate students who endorse non-medical 
prescription stimulant use would report higher ratings of internal restlessness compared 
to those who do not, a series of univariate ANOVAs were conducted with the dependent 
variables of interest being the total score and factor scores (internal distractibility, 
internal impulsivity, internal restlessness, and internal disorganization) of the IRS.   
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Regarding self-reported levels of mental restlessness, ANOVA results, consistent 
with Hypothesis 5,  revealed a small but significant group effect for overall restlessness, 
as measured by the total score of the IRS.  Results were significant at the .01 level: F 
(1,799) = 27.73, p < .001, η² = .034, suggesting that students who endorsed previous non-
medical use of prescription stimulants reported experiencing higher levels of mental 
restlessness than peers who did not report previous non-medical use. 
Regarding self-reported levels of internal distractibility, ANOVA results revealed 
a medium significant group effect, as measured by the Internal Distractibility subscale 
score of the IRS. Results were significant at the .01 level: F (1,799) = 17.96, p < .001, η² 
= .022, suggesting that students who endorsed previous non-medical use of prescription 
stimulants reported experiencing higher levels of internal distractibility than peers who 
did not report previous non-medical use.  
Regarding self-reported levels of internal impulsivity, ANOVA results revealed a 
small but significant group effect, as measured by the Internal Impulsivity subscale score 
of the IRS. Results were significant at the .01 level: F (1,799) = 11.02, p = .001, η² = 
.013, suggesting that students who endorsed previous non-medical use of prescription 
stimulants reported experiencing higher levels of internal impulsivity than peers who did 
not report previous non-medical use. 
Regarding self-reported levels of internal restlessness, ANOVA results revealed a 
small to moderate significant group effect, as measured by the Internal Restlessness 
subscale score of the IRS. Results were significant at the .01 level: F (1,799) = 59.30, p 
<.001, η² = .069, suggesting that students who endorsed previous non-medical use of 
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prescription stimulants reported experiencing higher levels of internal restlessness than 
peers who did not report previous non-medical use.  
Regarding self-reported levels of internal disorganization, ANOVA results 
revealed a small but significant group effect, as measured by the Internal Disorganization 
subscale score of the IRS. Results were significant at the .01 level: F (1,799) = 7.67, p = 
.006, η² = .010, suggesting that students who endorsed previous non-medical use of 
prescription stimulants reported experiencing higher levels of internal disorganization 
than peers who did not report previous non-medical use. 
Ancillary Analyses: Predictors of the Non-Medical Use of Prescription Stimulants 
Preliminary Pearson product-moment correlations were calculated to explore the 
relationships between total and subscale scores of the SSQ with the ASES, IRS, and 
DASS-21 (see Tables 5-7). Pearson product-moment correlations revealed that self-
reported stimulant use, as measured by Factor 1 subscale score on the SSQ, was 
significantly correlated with a perception of safety of prescription stimulant medications, 
as measured by Factor 4 subscale score on the SSQ (r = .209, p < .01).  Pearson product-
moment correlations also revealed that self-reported stimulant use was significantly 
correlated with total (r = .220, p < .01) and subscale scores of the IRS (Internal 
Distractibility: r = .163, p < .01; Internal Restlessness: r = .258, p < .01; Internal 
Impulsivity: r = .126, p < .01; Internal Disorganization: r = .193, p < .01).  Further 
correlations revealed that, while self-reported stimulant use was not significantly 
correlated with academic self-efficacy, it was significantly correlated with DASS-21 
subscale scores for Depression (r = .108, p < .01), Anxiety (r = .083, p < .01), and Stress 
(r = .116, p < .01). 
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To explore which of the assessed variables most strongly predicted ratings the 
Self-Reported Stimulant Use subscale of the SSQ, a post-hoc standard multiple regression 
analysis was conducted using the Perception of Safety of Stimulants generated by the 
SSQ, the academic self-efficacy ratings generated by the ASES, the total and subscale 
values of internal restlessness generated by the IRS, and the depression, anxiety and 
stress scores generated by the DASS-21 and as predictor variables. The full model 
explained a small amount of variance in the criterion variable (adjusted R² = .11), F 
(10,796) = 12.007, p < .001. Four significant predictor variables were revealed: the ASES 
total score, t (796) = 2.659, p = .008; the SSQ Factor 4 subscale score, t (796) = 5.436, p 
< .001; the IRS Internal Restlessness subscale score t (796) = 5.765, p < .001; and the 
IRS Internal Disorganization subscale score t (796) = 2.612, p = .009. Higher rates of 
non-medical stimulant use were positively associated with internal restlessness, internal 
distractibility, academic self-efficacy, and a greater perception of safety regarding the 
non-medical use of prescription stimulant medication. Additional statistics pertaining to 
the regression model are presented in Table 12.  
Finally, additional post-hoc analyses were conducted to explore possible 
variations in self-reported stimulant use across reported ethnicity, gender, and terminal 
degree of the graduate program in which students were enrolled. A series of one-way 
ANOVA’s were conducted, with ethnicity, gender, and terminal degree serving as 
independent variables, and the Self-Reported Stimulant Use subscale of the SSQ as 
dependent variable.  Results revealed significant but small group effects for self-reported 
ethnic group membership: F (1, 799) = 4.238, p < .001, η² = .037; as well as for terminal 
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degree indicated: F (1, 799) = 10.835, p < .001, η² = .038.  No significant group effect for 
gender was observed: F (1, 799) = 2.754, p = .064. 
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Discussion 
While a number of investigations have been conducted in recent years examining 
the prevalence and nature of non-medical prescription stimulant use among university 
students, the present study is the first to exclusively explore non-medical prescription 
stimulant use among a general sample of graduate students.  Past-year rates of self-
reported non-medical use were determined to be lower than hypothesized across the full 
sample. Nevertheless, previous usage rates were quite high overall, with 17.5% of 
participants reporting previous non-medical prescription stimulant use. Motivations for 
use reported by participants were both academic and social in nature, although a greater 
emphasis was observed on academically-motivated use, as compared to previously 
reported motivations among undergraduate students. Self-reported non-medical use of 
prescription stimulant medications was observed to correlate with self-reported levels of 
anxiety, depression, and stress, various aspects of internal restlessness, and perceived 
safety of the medications. Contrary to expectations, academic self-efficacy was not 
significantly associated with non-medical stimulant use. A regression model suggested 
that, while the above psychological variables may be positively correlated with non-
medical stimulant use, only internal disorganization, internal restlessness and the 
perception of safety of stimulant medications effectively predicted the non-medical use of 
prescription stimulants. 
The first hypothesis of the investigation proposed that non-medical use of 
stimulants would be reported among graduate students at rates similar to those reported 
by professional and medical students (8% or greater reporting non-medical use over the 
past 12 months). In fact, past-year usage rates for participants were somewhat lower than 
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hypothesized: while a notable proportion of participants (reported having previously used 
prescription stimulants for non-medical purposes, many fewer students (5.9% of 
participants) reported non-medical use of prescription stimulant use within the past year. 
Various factors could have contributed to a lower rate of past-year use being observed in 
the present sample. The current sample was disproportionately female, and previous 
investigations of non-medical stimulant use among undergraduates have suggested that 
usage rates are higher among male students (e.g. Low et al., 2002; Teter et al., 2005). 
Additionally, the present study included students from a wide variety of programs, while 
two of the three previous studies on non-medical stimulant use that included graduate-
level students surveyed students from programs that may give them increased knowledge 
of or access to prescription stimulant medications: medical school students and students 
enrolled in an accelerated doctor of pharmacy program (Frick, Frick, Coffman & Dey, 
2011; Tuttle, Scheurich & Ranseen, 2010). 
The most frequently cited motivations for self-reported use of stimulant 
medications related to academic activities: general academic performance, focus in class, 
and test performance were all noted by students as reasons they had used the medications 
previously.   Again, these findings are consistent with previous research conducted with 
undergraduate students that identified academic concerns as primary motivators for non-
medical stimulant use (DuPont et al., 2008; Dussault & Weyandt, 2013; Judson & 
Langdon, 2009; Teter et al., 2005; White et al., 2006). Also consistent with previous 
research with undergraduate students was the finding that students reported previous non-
medical use that was recreational in nature, endorsing the use of stimulant medications 
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while at parties, with alcohol, or to “get high” (Babcock & Byrne, 2000; DuPont et al., 
2008; Dussault & Weyandt, 2013; Teter et al., 2005).  
Results also provided insight into graduate student behaviors and beliefs 
regarding stimulant use among peers. More than one in four participants reported having 
been offered prescription stimulant medication by other students, and a smaller 
proportion of students reported having purchased the medications from peers. Academic 
activities were the most frequently cited perceived motivation for the use of stimulants 
among classmates, and participants reported knowledge of peers using the medications 
during tests and while studying. Relatively lower rates of perceived use among peers 
during social activities was reported, with about half as many participants reporting that 
their classmates were using stimulants non-medically at parties, with alcohol, or with 
other illicit substances. This discrepancy in reported academic versus non-academic 
motivations for use is more significant than that observed in previous research with 
undergraduates, where rates are more similar across the two domains (DuPont et al., 
2008; Dussault & Weyandt, 2013; Teter et al., 2005). Because these data relate to 
perceived use by others rather than self-reported use by the individual, it is unclear how 
accurate these perceptions may be. It is plausible that academic motivations for non-
medical use are more salient motivators for graduate students as compared to 
undergraduate students. It is also possible, however, that graduate students may be less 
likely to disclose their non-medical prescription stimulant use to peers, particularly if 
motivations are less socially acceptable, as with recreational use. Previous investigations 
with undergraduate students have indicated that perceived social norms surrounding non-
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medical use of stimulants is associated with self-reported usage (Judson & Langdon, 
2009).  
Results of the present study regarding the prevalence and nature of non-medical 
stimulant use among undergraduates likewise indicated that the medications appear quite 
accessible on campus, and perceived as relatively safe among students, with nearly one in 
four participants indicating a belief that “using prescription stimulants occasionally is 
harmless.” About a third of students indicated that they feel “knowledgeable about 
prescription stimulants” and about “the side effects of prescription stimulants.” Again, 
these results are largely consistent with previous investigations of non-medical use 
among undergraduate students regarding availability and safety of the medications 
(Dussault & Weyandt, 2013; Judson & Langdon, 2009; Weyandt et al., 2010)    
  The second hypothesis, which proposed that graduate students who endorse 
greater non-medical prescription stimulant use would report greater perceived self-
knowledge regarding stimulants and regard stimulant use as being safer than graduate 
students who do not use stimulants, was supported.  Results revealed a small but 
significant group effect for perception of safety, as students who reported a history of 
non-medical prescription stimulant use endorsed prescription stimulants as being safer 
than peers who did not report previous non-medical use.  These findings are consistent 
with previous investigations of non-medical prescription stimulant use among 
undergraduate students (Dussault & Weyandt, 2013; Judson & Langdon, 2009), as well 
as with the considerable body of research that associates perceived safety with risk for 
use of alcohol and other illicit substances among adolescents and adults. This result, in 
combination with the finding noted previously that many participants endorsed the 
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medications as relatively safe, or even “harmless,” is troubling, and suggests that future 
prevention and intervention strategies may benefit from the inclusion of a 
psychoeducational component that targets false perceptions of safety surrounding non-
medical prescription stimulant use. The U.S. Department of Education’s Higher 
Education Center for Alcohol and other Drug Abuse and Violence Prevention (2011) has 
identified five areas of strategic intervention that have been found to be effective in 
altering alcohol and drug use behaviors in a university setting, which include offering 
ample access to substance-free social, extracurricular, and public service options, creating 
a health-promoting normative environment, restricting the marketing and promotion of 
alcohol and other drugs both on and off campus, limit availability of alcohol and other 
drugs, and the development and enforcement of campus policies and enforce laws to 
address high-risk and illegal alcohol and other drug abuse and violence. Future studies 
should adapt these research-based interventions to include non-medical prescription drug 
use to investigate generalizability of the intervention. 
The third hypothesis, which proposed that graduate students who endorsed non-
medical prescription stimulant use would report lower academic self-efficacy ratings 
compared to those who did not, was not supported. Upon initial analysis, a small but 
significant group effect was revealed indicating that students who endorsed previous non-
medical use of prescription stimulants did not report lower levels of overall academic 
self-efficacy than peers who did not report previous non-medical use. The relationship 
between academic self-efficacy and non-medical use of prescription stimulant 
medications had not been previously researched, although the relationship between 
reported use and other academic variables has been investigated. Objective measures of 
 54 
academic performance such as GPA have been considered in previous research with 
undergraduates, with results indicating that students who are experiencing less academic 
success report higher rates of non-medical stimulant use (DuPaul et al., 2009; Rabiner et 
al., 2009; Shillington et al., 2009; Weyandt et al., 2010). While the results of these 
previous investigations have suggested that academic difficulties are associated with non-
medical prescription stimulant use, the nuances of the relationship remained unclear. By 
including academic-self-efficacy in the present investigation, it was hoped that greater 
insight regarding directionality would be provided. Researchers have previously 
questioned whether academic failure (and the associated psychological distress) is a risk 
factor for stimulant use, or whether the reverse is true- that is, that non-medical stimulant 
use may be a risk factor for academic failure. The results of the present investigation do 
not directly address this question, but do provide additional information about the 
relationship between academic strain and non-medical use of prescription stimulants.  
Participants in the present study were not asked to report GPA, as typically, relatively 
high GPAs are required in order to maintain enrollment in a graduate program. Instead, 
the ASES invited students to indicate how equipped they felt to achieve a number of 
specific programmatic goals, such as their ability to complete their degree in a timely 
manner, to handle the course work in their program, to conduct required research, and to 
handle associated stress. Students who reported the non-medical use of prescription 
stimulants were no likelier than peers to demonstrate low self-efficacy as measured by 
the ASES, suggesting that, while actual academic failure may be a risk factor for non-
medical stimulant use among university students, subjective academic stress does not 
appear to be a risk factor, at least among graduate students.  
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The fourth hypothesis, which proposed that graduate students who endorse non-
medical prescription stimulant use would report higher ratings of depression, anxiety and 
stress, was partially supported. Significant, albeit small effects emerged for Anxiety and 
Stress subscales, indicating that students who endorsed previous non-medical use of 
prescription stimulants reported higher levels of anxiety symptomatology and higher 
levels of perceived stress than peers who did not report previous non-medical use. The 
hypothesis was not supported regarding self-reported levels of depressive 
symptomatology. Previous research among undergraduate university students has 
suggested that psychological factors are significantly associated with non-medical 
stimulant use, including depression (Rabiner et al., 2009b; Teter et al., 2010; Weyandt et 
al., 2009) anxiety (Dussault & Weyandt, 2013; Weyandt et al., 2009), and stress (Janusis 
& Weyandt, 2010). The results of the present study are consistent with the results of 
Dussault and Weyandt (2013), who also assessed depression, anxiety and stress levels 
using the DASS-21 and observed associations for anxiety and stress, but not depression. 
In previous studies that did observe a significant association between self-reported 
depressive symptomatology and non-medical stimulant use, other measures were used to 
assess depression (e.g. the Brief Symptom Inventory, Derogatis & Melisaratos, 1993; 
Center for Epidemiologic Studies Depression Scale, Radloff, 1977). Because results of 
previous investigations do support an association between depressive symptomatology 
and non-medical stimulant use, it is unclear whether a lack of observed relationship in the 
two studies which used the DASS-21 may be a function of the instrument rather than the 
true absence of symptomatology among participants who report non-medical stimulant 
use. Future studies examining depressive symptomatology would likely benefit from the 
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inclusion of a more comprehensive instrument, such as the Brief Symptom Inventory,  
Beck Depression Inventory, or a structured interview.  Nevertheless, in the present study, 
students who reported non-medical use of prescription stimulants did not report 
significantly more depressive symptomatology than peers, but did report significantly 
higher levels of anxiety and stress. These findings are not causal in nature, but suggest 
that students who are experiencing significant levels of anxiety and stress may be at 
increased risk for non-medical use of prescription stimulant medication.  
 The fifth hypothesis, which proposed that graduate students who endorsed non-
medical prescription stimulant use would report higher ratings of internal restlessness 
compared to those who did not, was supported. Results revealed a small but significant 
group effect for overall mental restlessness, internal distractibility, internal impulsivity, 
internal restlessness, and internal disorganization. These results are consistent with results 
from previous investigations examining the non-medical use of prescription stimulants 
among undergraduate students (Dussault & Weyandt, 2013; Weyandt et al., 2009), 
suggesting that students who are experiencing significant levels of internal restlessness, 
distractibility, impulsivity, or disorganization may be at increased risk for non-medical 
use of prescription stimulant medication. High levels of internal restlessness have 
previously been observed among adults with ADHD (Biederman et al, 2009; Weyandt et 
al., 2003), which raises the possibility that students may be engaging in non-medical use 
of prescription stimulants in an effort to address elevated ADHD symptomatology or to 
self-medicate undiagnosed ADHD. 
 Correlational analyses explored the relationships between self-reported non-
medical stimulant use, perceived safety of stimulant medication use, academic self 
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efficacy, internal restlessness, depression, anxiety, and stress. Analyses revealed that self-
reported stimulant use was significantly correlated with a perception of safety of 
prescription stimulant medications, internal distractibility, internal restlessness, internal 
impulsivity, internal disorganization, depression, anxiety, and stress. It should be noted 
that most of the correlations were small, and did not all translate to meaningful between-
group differences, as detailed previously. Nonetheless, the associations are consistent 
with previous investigations of non-medical use of prescription stimulant medications 
among undergraduates, which have associated elevations in non-medical use with 
elevated levels of: perceived safety of use (Dussault & Weyandt, 2013; Judson & 
Langdon, 2009), depression (Rabiner et al., 2009b; Teter et al., 2010; Weyandt et al., 
2009) anxiety (Dussault & Weyandt, 2013; Weyandt et al., 2009), stress (Janusis & 
Weyandt, 2010), and internal restlessness (Dussault & Weyandt, 2013; Weyandt et al., 
2009). Although these observed relationships are not causal in nature, it is reasonable to 
consider each as a potential risk factor for non-medical use of prescription stimulant 
medication among graduate students in addition to their undergraduate counterparts, and 
to use this knowledge to responsibly inform future investigations upon which prevention 
and intervention strategies may be based.   
Regression analyses were conducted in an effort to identify which of the assessed 
variables might serve as predictors of non-medical stimulant use. The full model 
explained only a small amount of variance, and few significant predictor variables were 
revealed, including perception of safety of stimulant medication, internal restlessness, 
and academic self-efficacy. These results were somewhat consistent with regression 
analyses in a previous investigation of non-medical use among undergraduates (Dussault 
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& Weyandt, 2013), which identified internal restlessness as a valid predictor, but also 
identified anxiety and stress as predictors, which was not replicated in the current 
investigation.  Consideration of these findings, along with results of the correlational 
analyses and results of the regression analyses suggest that a relationship exists between 
the non-medical use of prescription stimulant medications by graduate students and 
identified psychological factors (e.g. perception of safety, depression, anxiety, stress). 
Results further indicate, however, that the identified factors cannot effectively predict 
use. It is likely that currently unidentified factors exist and are contributing to elevations 
in both psychological distress and non-medical stimulant use among students, and future 
studies should endeavor to uncover these factors. 
Limitations and Future Directions 
The present study has a number of limitations that should be considered when 
interpreting the findings. The most substantial limitations concern the nature of the 
sample.  Although the sample was relatively large, participants were disproportionately 
white and female. Because the sample was one of convenience, it is important to note that 
participants may also differ from the population from which the sample was drawn in 
ways other than demographic characteristics. Because participation was voluntary, 
students who elected to participate may be more interested in the concepts being 
explored. Participants in the sample, therefore, may have stronger opinions or more 
familiarity regarding non-medical stimulant use, or a greater interest in/experience with 
the psychological variables of interest, such as depression, anxiety, stress, or internal 
restlessness. Future research should consider collaborating with graduate school 
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administrators to gain greater access to all enrolled students, and potentially using a 
stratified sampling technique to increase representativeness. 
 Another limitation of the present study was the relatively small number of 
students who reported non-medical use. Although unequal sample sizes may continue to 
be an issue, future studies may consider targeting a larger number of students to obtain a 
larger number of students who do report previous use, especially use within the past 
twelve months. Since psychological symptomatology was among the variables of interest 
for the present study, co-morbid diagnoses of participants were also a limitation. 
Although participants were asked to report any previous diagnoses, individuals who had 
previously been diagnosed with disorders other than ADHD (e.g. anxiety, depression, 
eating disorders) were not excluded from the sample. Future researchers may consider 
trying to establish a sample including only students with normative psychological 
functioning to help control for possible effects of the diagnosed students’ existing 
psychopathology. If students with existing diagnoses of mental illness are included in 
future studies, more thorough information regarding their mental health history should be 
gathered to differentiate past and present pathology among participants.  
 Although adequate (and in most cases, high) internal consistency was established 
for a majority of measures, relatively low internal consistency was observed on the SSQ 
Factor 3 (α = .63) and SSQ Factor 4 (α = .69). Future research including the SSQ, and 
particularly research examining subscale scores, may wish to undertake a full factor 
analysis prior to data collection, and consider removing items from the measure for the 
purposes of the study.  
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The online nature of the present study may also serve as a limitation. In web-
based research, sample bias may cause some groups to be excluded or underrepresented 
in the sample (Duda & Nobile, 2010; Wyatt, 2000).  Because of variation in rates of 
Internet access and usage, web-based surveys may under represent certain economic, 
racial, and gender groups, as well as individuals who are not literate, not computer-
literate, or not able to utilize computers because of disability (Rhodes, Bowie & 
Hergenrather, 2003).  Given the nature of the present sample, it seems unlikely that the 
online nature of the study interfered diminished sample representativeness, but future 
studies with non-student populations should attempt to control for possible bias. Further, 
informed consent is more difficult to truly obtain online, as it can be difficult to 
determine whether participants truly understand the risks associated with the study or to 
validate participant age or demographic information (Duda & Nobile, 2010; Mustanski, 
2001; Rhodes et al., 2003).  Still, the web-based nature of data collection has notable 
advantages, particularly when participants are asked to disclose sensitive information. 
Web-based research has been observed to increase respondent openness and full 
participation (Rhodes et al., 2003), and it has been suggested that an online format 
appears to reduce inhibitions and social desirability (Griffiths, 2009).  The literature also 
suggests that emerging adults, specifically, may feel more comfortable disclosing 
sensitive information in a web-based survey, rather than a method that involves face-to-
face interaction (Battles, 2010; Griffiths, 2009; Mustanski, 2001). 
Additional suggestions for future research include conducting similar research on 
a more ethnically diverse population. Future studies may also wish to compare usage 
rates for prescription stimulants between groups of students that would have greater 
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access to the medications (e.g. medical or pharmaceutical students) and their peers. 
Although previous research has indicated a link between academic performance and non-
medical stimulant use, no association was observed between academic self-efficacy and 
stimulant use.  Further exploration of the relationship between academics and stimulant 
use is warranted, especially regarding possible mediating or moderating factors between 
academic performance and non-medical stimulant use. Although the link between 
stimulant use and increased risk of cardiac events has been established, greater 
knowledge is also needed regarding actual outcomes for students. Future research may 
consider the collection of data on actual risk/medical events related to non-medical use of 
stimulants on campus, perhaps by collecting data through campus health centers or local 
hospitals. Finally, given the observed rates of use among young adults who are not 
pursuing higher education, future research exploring the association between non-medical 
use of stimulants and psychological factors may benefit from the inclusion of young 
adults from community populations.  
Conclusions 
While a number of investigations have been conducted in recent years that have 
examined the prevalence and nature of non-medical prescription stimulant use among 
university students, the present study is among the first to explore non-medical 
prescription stimulant use among graduate students.  Past-year rates of self-reported non-
medical use were determined to be lower than hypothesized and the hypothesized usage 
rate was observed at just one of the five universities included in the present study. 
Motivations for use reported by participants were both academic and social in nature, 
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although a greater emphasis was observed on academically-motivated use, as compared 
to previously reported motivations among undergraduate students.  
Self-reported non-medical use of prescription stimulant medications was observed 
to be significantly correlated with self-reported levels of anxiety, depression, and stress, 
various aspects of internal restlessness, and perceived safety of the medications. Contrary 
to the study’s hypothesis, academic self-efficacy was not significantly associated with 
non-medical stimulant use. A regression model suggested that, while psychological 
variables were positively correlated with non-medical stimulant use, only internal 
restlessness, internal disorganization, and the perception of safety of stimulant 
medications effectively predicted the non-medical use of prescription stimulants. In 
conclusion, the findings of the present study support the notion that non-medical use of 
prescription stimulants is problematic on university campuses, including the graduate 
student population. 
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Table 1. 
Demographic Characteristics of Participants from Universities Located in the 
Northeastern, Southeastern, Midwestern, Southwestern, and Northwestern United States 
Pertaining to Gender, Age and Ethnicity. 
 Southwest Southeast Midwest Northeast Northwest Total 
Gender       
Male 23.70% 20.80% 33.30% 27.00% 8.30% 26.00% 
Female 76.30% 77.10% 62.10% 73.00% 83.30% 72.10% 
Prefer not to say -- 2.10% 4.50% -- 8% 1.90% 
Age       
18-21 years  -- -- -- -- -- -- 
22-25 years 26.30% 25.00% 39.40% 46.00%  35.70% 
26-29 years 26.30% 29.20% 33.30% 30.00% 41.70% 30.10% 
30-34 years 21.10% 14.60% 24.40% 15.00% 33.30% 19.00% 
35-39 years 7.90% 14.60% 3.00% 2.00% 16.70% 6.30% 
40-44 years 5.30% 2.10% -- 3.00% 8.30% 3.00% 
45-49 years 2.60% 4.20% -- 1.00% -- 1.50% 
50+ years 7.90% 10.40% -- 3.00% -- 4.10% 
Ethnicity       
White/European American 65.80% 87.50% 59.10% 89.00% 66.70% 76.60% 
Latino/Hispanic American 13.20% 2.10% 18.20% 3.00% 16.70% 8.60% 
Asian/Asian American 7.90% 4.20% 9.10% 5.00% -- 6.30% 
Black/African American -- 2.10% 6.10% -- -- 1.90% 
Multiethnic 2.60% 2.10% 3.00% 2.00% -- 2.20% 
American Indian  2.60% -- -- -- -- 0.40% 
Other 2.60%  1.50% 1.00% -- 1.10% 
Prefer not to say 5.30% 2.10% 3.00% -- 16.70% 3.00% 
 64 
Table 2 
Demographic Characteristics of Participants from Universities Located in the 
Northeastern, Southeastern, Midwestern, Southwestern, and Northwestern United States 
Pertaining to Enrollment Status. 
 Southwest Southeast Midwest Northeast Northwest Total 
Degree Program        
Master's Level 86.80% 43.80% 12.10% 54.00% -- 43.50% 
Specialist Level 5.30% 2.10% -- 2.00% -- 1.90% 
Doctoral Level 7.90% 52.10% 87.90% 43.00% 100.00% 53.90% 
Other  -- 2.10% -- 1.00% -- 0.70% 
Graduate Program       
Computer Science/IT -- -- -- 1.00% -- 0.40% 
Education 21.10% 39.60% 1.50% 10.00% -- 14.50% 
Engineering 5.30%  7.60% 9.00% -- 6.30% 
Fine Arts & Design 13.20% 12.50% 1.30%  -- 4.50% 
Health Industry and Public 
Services  
5.30%  4.60% 4.00% -- 3.30% 
Humanities  18.40% 8.30% 7.60% 4.00% -- 7.40% 
Medical and Health Professions 5.30% -- 4.40% 10.00% -- 5.60% 
Mental Health Professions  5.30% --  1.00% -- 1.10% 
Sciences (Biomedical) 2.60% -- 37.90% 10.00% 50.00% 13.40% 
Sciences (Environmental) -- -- 3.00% 21.00% -- 8.60% 
Sciences (Natural/Physical) 2.60% -- 4.40% 1.00% -- 1.90% 
Social Sciences  5.30% 39.60% 25.80% 28.00% 50.00% 26.80% 
Other 15.80% -- 1.50% 8.00% -- 5.90% 
Prefer not to Say -- -- -- 1.00% -- 0.40% 
 
 65 
Table 3 
Demographic Characteristics of Participants from Universities Located in the 
Northeastern, Southeastern, Midwestern, Southwestern, and Northwestern United States 
Pertaining to Diagnostic Status of Mental Health Disorders and Physical Disabilities. 
 Southwest Southeast Midwest Northeast Northwest Total 
 (N = 115) (N = 144) (N = 198) (N = 300) (N = 36) (N = 807)  
       
Psychological Diagnoses 
      
Attention-Deficit 
Hyperactivity Disorder 
5.30% 16.70% 3.10% 11.00% 16.70% 9.30% 
Anxiety Disorder 13.20% 25.00% 21.20% 16.00% 33.30% 20.10% 
Depression Disorder 15.80% 27.10% 28.80% 19.00% 16.70% 21.90% 
Bi-Polar Depression 2.60% 2.10% 3.00% 2.00% 0.00% 2.20% 
Eating Disorder -- 6.30% 1.50% 4.00% 0.00% 3.00% 
Specific Learning 
Disability 
5.30% 4.20% 3.00% 4.00% 0.00% 3.70% 
Physical Diagnoses       
Major Physical Disability 5.30% -- 1.50% 2.00% -- 1.90% 
Currently Registered with 
Disability Support Services 
-- --   -- -- 
Yes 2.60% -- 4.50% 1.00% -- 1.90% 
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Table 4 
Means, Standard Deviations, and Internal Consistencies (as Measured by Cronbach’s 
Alpha Scores) of: SSQ Total Score, SSQ Factor 1, SSQ Factor 2, SSQ Factor 3, SSQ 
Factor 4, IRS Total Score, IRS Factor 1, IRS Factor 2, IRS Factor 3, IRS Factor 4, 
DASS-21 Factor 1, DASS-21 Factor 2, DASS-21 Factor 3, and ASES Total Score.  
 M SD Α 
SSQ Total 64.71 7.38 .75 
SSQ Factor 1
a
 27.80 7.11 .87 
SSQ Factor 2
 b
 14.11 2.39 .89 
SSQ Factor 3
c
 8.41 1.24 .63 
SSQ Factor 4
d
 8.87 2.61 .69 
IRS Total 74.3 19.69 .94 
IRS Factor 1
e
 26.36 7.91 .89 
IRS Factor 2
f
 7.39 2.86 .79 
IRS Factor 3
g
 17.04 5.42 .88 
IRS Factor 4
h
 9.11 3.02 .77 
DASS-21 Factor 1
i
 10.77 4.07 .89 
DASS-21 Factor 2
j
 9.52 2.83 .76 
DASS-21 Factor 3
k
 12.80 4.11 .87 
ASES Total   25.03 3.31 .79 
a 
SSQ Factor 1 = Self-Reported Use of Prescription Stimulants; 
b 
SSQ Factor 2 = Perception of Prevalence 
of Prescription Stimulant Use Among Peers; 
c 
SSQ Factor 3 = Knowledge of Atypical Stimulant Use 
Among Peers; 
d 
SSQ Factor 4 = Perception of Safety of Prescription Stimulant Medication; 
e 
IRS Factor 1 = 
Internal Distractibility;
 f 
IRS Factor 2 = Internal Restlessness; 
g 
IRS Factor 3 = Internal Impulsivity; 
h 
IRS 
Factor 4 = Internal Disorganization;  
I 
DASS-21 Factor 1 = Depression; 
j 
DASS-21 Factor 2 = Anxiety; 
k
DASS-21 Factor 3 = Stress.  
 67 
Table 5 
Intercorrelations Between Total and Factor Scores of the IRS and SSQ.  
 
SSQ 
Total 
SSQ 1
a
 SSQ 2
b
 SSQ 3
c
 SSQ 4
d
 IRS 
Total 
IRS 1
e
 IRS 2
 f
 IRS 3
 g
 
SSQ Factor 
1
a
 
.866**         
SSQ Factor 
2
b
 
.003 -.205**        
SSQ Factor 
3
c
 
.106** .001 .723**       
SSQ Factor 
4
d
 
.450** .209** -.088* -.069*      
IRS Total .184** .220** -.130** .008 .106**     
IRS 1
e
 .127** .163** -.138** -.034 .093** .934**    
IRS 2
f
 .218** .258** -.128** -.021 .058 .730** .590**   
IRS 3
g
 -.356** .126** .145** -.034 .077* .834* .730** .482**  
IRS 4
h
 .197** .193** -.105** .009 .176** .622** .496** .386** .395** 
a 
SSQ Factor 1 = Self-Reported Use of Prescription Stimulants; 
b 
SSQ Factor 2 = Perception of Prevalence 
of Prescription Stimulant Use Among Peers; 
c 
SSQ Factor 3 = Knowledge of Atypical Stimulant Use 
Among Peers; 
d 
SSQ Factor 4 = Perception of Safety of Prescription Stimulant Medication; 
e 
IRS Factor 1 = 
Internal Distractibility;
 f 
IRS Factor 2 = Internal Restlessness; 
g 
IRS Factor 3 = Internal Impulsivity; 
h 
IRS 
Factor 4 = Internal Disorganization. 
** Correlation is significant at the .01 level (two-tailed) 
* Correlation is significant at the .05 level (two-tailed) 
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Table 6 
Intercorrelations Between SSQ Total and Factor Scores and Factor Scores of the DASS-
21.  
 SSQ Total SSQ 1
a
 SSQ 2
b
 SSQ 3
c
 SSQ 4
d
 DASS 1
e
 DASS 2
f
 
DASS-21
e
 
Factor 1 
.123** .108** .055 .129** .116**   
DASS-21 
Factor 2
f
 
.063 .083** -.019 .025 .104** .515**  
DASS-21 
Factor 3
g
 
.118** .116** .051 .110** .106** .631** .638** 
a 
SSQ Factor 1 = Self-Reported Use of Prescription Stimulants; 
b 
SSQ Factor 2 = Perception of Prevalence 
of Prescription Stimulant Use Among Peers; 
c 
SSQ Factor 3 = Knowledge of Atypical Stimulant Use 
Among Peers; 
d 
SSQ Factor 4 = Perception of Safety of Prescription Stimulant Medication; 
e 
DASS-21 
Factor 1 = Depression;
 f 
DASS-21 Factor 2 = Anxiety; 
g 
DASS-21 Factor 3 = Stress.  
** Correlation is significant at the .01 level (two-tailed) 
* Correlation is significant at the .05 level (two-tailed) 
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Table 7 
Intercorrelations Between SSQ Total and Factor Scores and ASES Total Score.  
 SSQ Total SSQ 1
a
 SSQ 2
b
 SSQ 3
c
 SSQ 4
d
 
ASES -0.39 -.034 .002 -.009 -.092** 
a
 SSQ Factor 1 = Self-Reported Use of Prescription Stimulants; 
b
 SSQ Factor 2 = Perception of Prevalence 
of Prescription Stimulant Use Among Peers; 
c
 SSQ Factor 3 = Knowledge of Atypical Stimulant Use 
Among Peers; 
d
 SSQ Factor 4 = Perception of Safety of Prescription Stimulant Medication. 
** Correlation is significant at the .01 level (two-tailed) 
* Correlation is significant at the .05 level (two-tailed) 
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Table 8 
Stimulant Survey Questionnaire Responses Pertaining to the Nature of and Motivations 
for Self-Reported Use of Prescription Stimulants Among Graduate Students.  
 
Never Rarely Occasionally Frequently Always Total 
Use 
I have used prescription stimulants 
for non-medical purposes. 
82.2% 11.2% 5.9% 0.4% -- 17.5% 
I have used prescription stimulants 
at parties. 
90.7% 6.3% 2.2% 0.4% -- 8.9% 
I have used prescription stimulants 
with alcohol. 
89.2% 7.4% 3.3% -- -- 10.7% 
I have snorted prescription 
stimulants. 
96.3% 2.6% 0.7% 0.4% -- 3.7% 
I have injected prescription 
stimulants. 
100.0 
% 
-- -- -- -- -- 
I have smoked prescription 
stimulants. 
97.8% 1.1% 0.4% 0.4% -- 1.9% 
 I have taken prescription 
stimulants to focus better in class. 
88.5% 5.2% 3.3% 1.1% 1.1% 10.7% 
I have taken prescription 
stimulants to perform better on 
tests.  
89.9% 5.9% 2.6% 0.4% 1.1% 10.0% 
I have taken prescription 
stimulants to help me socialize 
better. 
92.5% 4.5% 2.2% -- 0.7% 7.4% 
I have taken prescription 
stimulants to help me lose weight. 
97.0% 1.5% 0.4% 0.4% 0.7% 3.0% 
I have taken prescription 
stimulants to perform better in my 
schoolwork 
83.8% 8.3% 4.5% 1.9% 1.5% 16.2% 
I have taken prescription 
stimulants to feel more energetic.  
87.7% 5.2% 4.5% 1.9% 0.7% 12.3% 
I have taken prescription 
stimulants to feel better about 
myself.  
95.1% 1.1% 1.9% 1.5% 0.4% 4.9% 
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I have taken prescription 
stimulants to “get high”.  
92.1% 4.1% 3.0% 0.7% -- 7.8% 
I have been offered prescription 
stimulants by other students. 
71.7% 20.4% 5.6% 1.5% 0.4% 27.9% 
I have tried someone else’s 
prescription stimulant medication.  
82.9% 11.9% 3.3% 0.7% 0.4% 16.3% 
I have purchased prescription 
stimulants from other students. 
95.4% 3.0% 1.1% 0.4% -- 4.5% 
I have sold prescription stimulant 
medication to other students. 
99.9% -- -- -- -- -- 
I have given prescription stimulant 
medication to other students.  
98.1% 1.5% 0.4% -- -- 1.9% 
I have been pressured to let others 
have my prescription stimulant 
medication.                 
98.9% 1.1% -- -- -- 1.1% 
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Table 9 
Stimulant Survey Questionnaire Responses Pertaining to the Expressed Attitudes and 
Perceptions of Graduate Students Regarding the Non-Medical Use of Prescription 
Stimulants.  
 
Strongly 
Disagree 
Disagree Neutral Agree 
Strongly 
Agree 
Prescription stimulants are easy to get on this 
campus. 
3.8% 9.9% 71.1% 12.9% 2.3% 
Prescription stimulants are as easy to get as 
alcohol. 
16.9% 29.1% 49.1% 4.2% 0.8% 
Prescription stimulants are as easy to get as 
marijuana. 
6.1% 16.7% 56.8% 17.8% 2.7% 
Using prescription stimulants occasionally is 
harmless. 
18.6% 31.2% 25.3% 23.0% 1.9% 
Using prescription stimulants daily is 
harmless. 
45.4% 32.3% 19.3% 2.6% 0.4% 
Prescription stimulant use on campus is a 
problem. 
3.0% 9.7% 64.0% 18.4% 4.9% 
Prescription stimulants are safer than 
marijuana. 
26.2% 43.1% 28.5% 1.9% 0.4% 
Prescription stimulants are safer than alcohol. 14.9% 38.1% 39.2% 7.1% 0.7% 
I feel I am knowledgeable about prescription 
stimulants. 
11.5% 33.1% 24.9% 23.4% 7.1% 
I feel I am knowledgeable about the side 
effects of prescription stimulants. 13.0% 32.3% 21.9% 26.0% 6.7% 
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Table 10 
Stimulant Survey Questionnaire Responses Pertaining to Perceived Non-Medical Use of 
Prescription Stimulants Among Peers.  
 Yes No 
I know students who use prescription stimulants at parties. 20.4% 79.6% 
I know students who use prescription stimulants with alcohol. 22.1% 77.9% 
I know students who use prescription stimulants with other drugs. 18.9% 80.1% 
I know students who use prescription stimulants while studying.                       43.8% 56.2% 
I know students who use prescription stimulants during finals week. 44.0% 55.9% 
I know students who use prescription stimulants during tests. 36.0% 64.0% 
I know students who snort prescription stimulants. 7.6% 92.4% 
I know students who inject prescription stimulants. 0.4% 99.6% 
I know students who smoke prescription stimulants. 1.5% 98.5% 
I hide my prescription stimulant medication so that no one will take it. 3.1% 96.8% 
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Table 11  
Differences in the Perception of Safety of Stimulant Use, Reported Self-Efficacy, 
Depression, Anxiety, Stress, and Internal Restlessness Among Students Who Do and Do 
Not Report the Non-Medical Use of Prescription Stimulant Medication. 
 Students Endorsing 
Non-Medical Use 
Students Not Endorsing 
Non-Medical Use 
Effect 
Size 
ANOVA F 
test results 
Variable N Mean SD N Mean SD η²  
Lifetime Use         
SSQ Factor 4: 
Perception of Safety 
129 10.21 1.69 672 9.40 2.217 η² = 
.0186 
F(1,799) = 
15.197, p < 
.001** 
         
ASES Total Score 129 24.47 3.08 672 25.09 3.36 η² = 
0.005  
F(1,799) = 
3.926, p = 
.048* 
         
DASS-21:  
Depression Total 
Score 
129 11.33 3.47 672 10.63 4.16 η² = 
0.004  
F(1,799) = 
3.221, p = 
.073 
DASS-21:  Anxiety 
Total Score 
129 10.34 3.29 672 9.38 2.77 η² 
=.015 
F(1,799) = 
12.44, p < 
.001** 
DASS-21:  Stress 
Total Score 
129 14.16 4.20 672 12.52 4.02 η² = 
.022  
F(1,799) = 
17.75, p < 
.001** 
         
IRS: Total Score 129 82.63 20.28 672 72.75 19.35 η² = 
.034  
F(1,799) = 
27.73, p < 
.001** 
IRS: Internal 
Distractibility Score 
129 28.91 7.47 672 25.71 7.92 η² = 
0.022  
F(1,799) = 
17.96, p < 
.001** 
IRS: Internal 
Impulsivity Score 
129 18.44 5.52 672 16.71 5.38  η² = 
0.013 
F(1,799) = 
11.02, p = 
.001**  
IRS: Internal 
Restlessness Score 
129 9.09 3.80 672 7.04 2.52 η² = 
0.069  
F(1,799) = 
59.30, p 
<.001** 
IRS: Internal 
Disorganization 
Score 
129 9.79 3.33 672 8.99 2.96 η² = 
0.010 
F(1,799) = 
7.67, p = 
.006** 
**Significant at the p < .01 level 
*Significant at the p < .05 level 
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Table 12 
Summary of Standard Multiple Regression Analyses for Academic Self-Efficacy, 
Perception of Safety of Prescription Stimulant Medication, Internal Distractibility, 
Internal Restlessness, Internal Impulsivity, Internal Disorganization, Depression, Anxiety 
and Stress Predicting SSQ Factor One: Self-Reported Prescription Use. 
Predictor B SE B β p- value R² Adjusted 
R² 
Step 1     .119 .109 
Academic Self Efficacy 
 a
 .224 .084 .105 .008**   
Perception of Safety of Prescription Stimulant 
Medication
 b
 
.604 .111 .184 < .001**   
Internal Distractibility 
c
 -.045 .050 -.050 .371   
Internal Restlessness 
d
 .605 .105 .245 <.001**   
Internal Impulsivity 
e
 .027 .075 .021 .721   
Internal Disorganization 
f
 .262 .100 .112 .009**   
Depression 
g
 .072 .085 .041 .393   
Anxiety 
h
 -.122 .111 -.050 .271   
Stress 
i
 .068 .095 .039 .473   
a 
ASES Total Score; 
b 
SSQ Factor 4; 
c 
IRS Factor 1; 
d 
IRS Factor 2;
  
;
 e 
IRS Factor 3; 
 f 
IRS Factor 4; 
g 
DASS-
21 Factor 1; 
h 
DASS-21 Factor 2; 
I 
DASS-21 Factor 3. 
** Correlation is significant at the .01 level  
* Correlation is significant at the .05 level  
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Appendix A:  
Content of Contact Email to University Faculty 
 
Dear Dr. [Insert Faculty Member Last Name]: 
I would like to extend the opportunity to invite your graduate students to take part in an 
anonymous research projects studying prescription stimulant misuse, psychological and 
academic functioning among graduate students. Results of this study will inform my 
dissertation project, which explores the relationship between misuse of prescription 
stimulants and several unique aspects of psychological and academic functioning. We 
will be collecting data from graduate students at five universities, including [Insert name 
of University here].  We are surveying students from a wide variety of graduate programs 
in an effort to get the perspective of as many students as possible, and the information 
that students in the [Insert name of specific graduate program here] program have to offer 
is very important to us.  
I would be grateful if you would be willing to email this link to your graduate students 
and/or post this link on a class website, inviting students to participate.  
This study is approved by the University of Rhode Island’s Institutional Review board, 
voluntary, and results will not be linked to any identifiable information. Respondents will 
be asked to answer questions about stimulant use, mood, and academic functioning. The 
survey is online, so they must access the survey on a computer that has internet access. 
The survey will take about 15 minutes to complete.  
 
Please post this link below: 
https://www.surveymonkey.com/s/Y53Z8JH 
  
Thank you for your help! If you have any questions, please feel free to contact me 
(genevieve_verdi@my.uri.edu or 401-270-8299), or my supervising faculty member, Dr. 
Lisa Weyandt (401-874-2087 or lisaweyandt@uri.edu). 
  
Best, 
Genevieve Verdi, M.Ed 
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Appendix B:  
Statement on Diversity in Research 
 Per the requirements identified by the Office of Research Compliance and the 
Institutional Review Board, this research Project will endeavor to include participants 
from both genders and a variety of cultural backgrounds in order to ensure that findings 
will equally benefit all individuals within the target population- in this case, graduate 
students. As stated in the dissertation proposal, graduate students from all graduate 
programs on the five identified campuses will be targeted for participation in order to 
obtain a representative sample, and no graduate student enrolled in a program on a full-
time basis at any of the target universities will be excluded.   
 The focus of this investigation is non-prescription stimulant use among graduate 
students, and although only a handful of studies have explored this phenomenon, 
investigations of stimulant use among undergraduate students have been conducted at 
each of the five targeted universities, which provides some insight into specific sub-
populations that may be at increased risk for non-medical prescription stimulant use, and 
this may benefit particularly from the information generated by this investigation. 
Overall, findings indicate that in terms of gender and ethnicity, students who are White 
and male are at increased risk to use prescription stimulants. At a multi-site study 
including participants from the University of Rhode Island, the University of Central 
Florida, and the University of Washington, male students (26%) were found to be at 
increased risk to use prescription stimulants non-medically as compared to female 
students (17.3%; Dussault & Weyandt, 2013).  In a previous study at the University of 
Rhode Island, no effects were found for ethnicity or gender with regard to non-medical 
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stimulant use among undergraduates (Weyandt et al., 2009).  At the University of 
Michigan, a number of investigations have explored prescriptions non-medical stimulant 
use among undergraduates, finding no gender effect for use, with one study observing 
that White students report greater non-medical use than peers from other ethnic 
backgrounds (McCabe & Teter, 2007; Sepulveda et al., 2011; Teter et al., 2010).  At the 
University Central Florida, small gender effects were found for non-medical prescription 
stimulant use, with male students reporting higher rates of use (Ford & Schroeder, 2009). 
At San Diego State University, male students were more likely to report non-medical 
prescription stimulant use within the past year (14.4%) than female students (9.1%), and 
a greater proportion of White students (14.5%) than Non-white students (6.1%) reported 
past-year use (Shillington et al., 2006).     
 An effort will be made to include participants who self-identify as White and 
male because they are at increased risk to use prescription stimulants without a 
prescription. An effort will also be made, however, to recruit a sample of students at each 
of the five targeted universities that is representative of the gender and ethnicity 
demographics of the graduate student population, and to include members of diverse 
ethnic backgrounds as well as females as participants. At the University of Rhode Island, 
2010 data states that the graduate student population is: 58% female, 65% White, 3% 
Latino, 3% Black/African American, and 4% Asian/Pacific Islander, with the remainder 
of students not reporting racial or ethnic identity.  At the University of Central Florida, 
2010 data states that the graduate student population is: 59% female, 62% White, 8% 
Latino, 10% Black/African American, and 4% Asian/Pacific Islander, with the remainder 
of students not reporting racial or ethnic identity.  At the University of Washington, 2010 
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data states that the graduate student population is: 53% female, 60% White, 5% Latino, 
3% Black/African American, 12% Asian/Pacific Islander, and 1% Native American, with 
the remainder of students not reporting racial or ethnic identity.  At the University of 
Michigan, 2010 data states that the graduate student population is: 46% female, 2% 
multi-racial, 52% White, 4% Latino, 4% Black/African American, and 10% Asian/Pacific 
Islander, with the remainder of students not reporting racial or ethnic identity. At San 
Diego State University, 2010 data states that the graduate student population is: 61% 
female, 2% multi-racial, 44% White, 16% Latino, 3% Black/African American, and 9% 
Asian/Pacific Islander, with the remainder of students not reporting racial or ethnic 
identity.  All of the demographic data above is based on Fall 2010 enrollment data, and is 
provided by the Institute of Education Sciences, National Center for Education Statistics 
of the U.S. Department of Education (http://nces.ed.gov/ipeds/datacenter/Data.aspx).  
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Appendix C: 
Debriefing Statement 
The study that you just participated in was examining misuse of prescription 
stimulant medications among graduate students, and the relationship between 
psychological variables, internal restlessness, academic self-efficacy, and stimulant 
misuse among college students.   This research, entitled, “An Examination of Non-
Medical Use of Prescription Stimulant Medication Use and Psychological Functioning in 
Graduate Students” is being conducted in order to fulfill requirements for a doctorate of 
philosophy degree in psychology.   
The prevalence of non-medical use of stimulant medications among college 
students has been well documented in research. This research seeks to assess prevalence 
rates among a sub-population of the college community (graduate students), and to 
further examine risk factors associated with stimulant use.  Results of this investigation 
may help to identify sub-populations of graduate students who are at risk for non-medical 
use of stimulant medication, and to inform prevention and intervention strategies 
designed to address non-medical prescription stimulant use. 
 If you have any questions or concerns about this study, please contact Genevieve 
Verdi at 401-270-8299.  Thank you for your time and participation.  
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Appendix D: 
Informed Consent Form 
The University of Rhode Island 
Department of School Psychology 
An Examination of Prescription Stimulant Misuse and Psychological Functioning in 
Graduate Students 
 
PLEASE PRINT AND KEEP THIS FORM FOR YOURSELF 
 
Dear Participant: 
 
You have been invited to take part in a research project described below. If you have any 
questions, please feel free to contact the student investigator, Genevieve Verdi Tubbs, at 
(401)-270-8299 or <genevieve_verdi@my.uri.edu>, or the faculty sponsor, Dr. Lisa 
Weyandt, at (401)-874-2194 or <lisaweyandt@uri.edu>.   
 
The purpose of this study is to examine the misuse of prescription stimulant medications 
and its relation to aspects of mental well-being (such as emotional state, anxiety, mental 
restlessness, etc.) and attitudes toward academic responsibilities and obligations. 
Responses to survey items are completely anonymous: there will be no identifying 
information linking you to your responses or to any particular organization.  Data will be 
encrypted and stored through the website SurveyMonkey, and only the primary student 
investigator will have access to the data through the use of a password. 
 
YOU MUST BE AT LEAST 18 YEARS OLD to participate in this research project.  If 
you are not, please discontinue the survey at this time.   
 
If you decide to participate in this study, it will involve completing some questionnaires 
pertaining to your perceptions about prescription stimulant medication, your overall well-
being, and your academic functioning.   
 
The possible risks of the study are minimal, although you may feel some embarrassment 
answering questions of a personal nature.  Please respond honestly, and remember that 
your responses are anonymous. 
 
Although there are no direct benefits of the study, your answers will help to increase 
knowledge about the complexities of non-prescription stimulant use on college campuses. 
 
Your participation in this study is anonymous. This means that your answers to all 
questions are private. No one else can know that you participated in this study, and no 
one can find out what your answers were to any items.  Scientific reports will be based on 
aggregated group data, and will not identify you or any individual in this project. 
 
The decision to participate in this research project is up to you.  You do not have to participate, 
and you can decline to answer the questionnaires. If you decide to take part in the study, you may 
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quit at any time. Whatever you decide will in no way penalize you or your status as a student.   
Participation in this study is not expected to be harmful or injurious to you. 
 
If you have any additional questions or concerns about this study, you may contact the student 
investigator, Genevieve Verdi, at (401)-270-8299, her faculty sponsor, Dr. Lisa Weyandt, at 
(401)-874-2194, or the University of Rhode Island’s Vice President for Research, 70 Lower 
College Road, Suite 2, URI, Kingston, RI; (401)874-4328. 
 
By clicking this box, you are indicating that: 
You are at least 18 years old.   
You have read the consent form and your questions have been answered to your satisfaction. 
Your completion of the surveys implies your consent to participate in this study. 
 
If these questions are upsetting and you want to talk please use the phone numbers below: 
 
The University of Rhode Island Counseling Center     
www.uri.edu/coun     
(401) 874-2288      
Roosevelt Hall, 2
nd
 floor 
 
The University of Central Florida Counseling Center 
www.counseling.sdes.ucf.edu/ 
(407) 823-2811 
Bldg. 27 
4000 Central Florida Blvd.  
 
San Diego State University Counseling and Psychological Services 
http://www.sa.sdsu.edu/cps/index.html 
(619) 594-5220 
Calpulli Center, Room 4401 
5500 Campanile Dr. 
 
The University of Washington Counseling Center 
https://depts.washington.edu/counsels/ 
(206) 543-1240 
401 Schmitz Hall 
 
The University of Michigan Counseling and Psychological Services 
http://www.umich.edu/~caps/ 
734.764.8312 
Michigan Union, Room 3100 
530 S. State Street 
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Appendix E: 
 
Demographic Information Form 
 
Instructions:  Please answer the following questions as completely and accurately as 
possible. 
 
1. Current Age:  
18-21 years 
22-25 years 
26-29 years 
30-34 years 
35-39 years 
40-44 years 
45-49 years 
50+ years 
 
2. Gender:  Male  Female Prefer Not to Say 
 
3. Ethnicity (Please circle one): White/European American Pacific Island 
     
Latino/Hispanic American Asian/Asian 
American 
     
Black/African American Multiethnic 
 
American Indian or Alaska Native 
 
Other ____________ 
 
4. University that you attend: 
 San Diego State University 
 University of Central Florida 
 University of Michigan 
 University of Rhode Island 
 University of Washington 
       Other ____________ 
 
 
5. Degree Program in which you are enrolled (please choose one):    
 Master’s Level 
 Specialist Level 
 Doctoral Level 
 Other (Please Specify degree) ___________ 
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6. Please select the category that best describes the type of Graduate Program in 
which you are enrolled: 
Architecture/Environmental Engineering/Built Environments/Urban 
Planning/Town Planning 
 Business/Business Administration/Hospitality 
Computer Science/Information Technology 
Education 
 Engineering 
Fine Arts & Design (e.g. Visual Arts, Performing Arts, Music, Theatre, Dance, 
etc.) 
Health Industry and Public Services (e.g. Health and Human Services/Health and 
Public Affairs/Public Health/Public Policy, etc.) 
 Humanities (e.g. History, Religion, Philosophy, etc.) 
Law 
Medical and Health Professions (e.g. Health Sciences, Dentistry, Medicine, 
Nursing, Pharmacy, etc.) 
 Mental Health Professions (e.g. Counseling, Social Work, etc.) 
Sciences (Biomedical) 
Sciences (Environmental: e.g. Natural Resources, Oceanography, Forestry, etc.) 
Sciences (Natural/Physical) 
Social Sciences (e.g. Psychology, Sociology, Anthropology, Economics, Political 
Science, etc.) 
Other: _________________________ 
Prefer not to Say 
 
7. Have you ever used prescription stimulant medication that was not prescribed to 
you? 
Yes  No 
8. Have you used prescription stimulant medication that was not prescribed to you in 
the past 12 months? 
Yes  No 
9. Have you ever been diagnosed with Attention-Deficit-Hyperactivity Disorder?   
Yes  No 
10. If you answered “yes” to Question 7, with what subtype of ADHD are you 
diagnosed? 
Hyperactive/Impulsive Type Inattentive Type  
Combined Type Do Not Know 
11. If you answered “yes” to Question 7, at what age were you first diagnosed? 
_______ 
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12. Are you currently taking stimulant medication that has been prescribed to you by 
a doctor, including methylphenidate (e.g. Ritalin, Concerta, Metadate) or 
amphetamine (Adderall, Dexedrine, Desoxyn, Vyvanse)?  
Yes  No 
13. If “yes,” what is the name of your medication? _____________________ 
14. If “yes,” have you ever used stimulant medication that was prescribed to you in a 
way other than the manner it was prescribed (e.g. higher or more frequent dosage, 
different method of ingestion)? 
Yes  No 
15. Please endorse any of the following psychological conditions that you have 
previously been or are currently diagnosed with: 
Anxiety Disorder 
Depression Disorder 
Bi-Polar Depression 
Eating Disorder 
Specific Learning Disability 
 
16. Do you currently have a major physical disability? 
 
Yes  No 
 
17. If “yes” to Question 15 or Question 16, are you currently registered with the 
Disabilities Support Services office at your university? 
 
Yes                  No 
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Appendix F: 
Stimulant Survey Questionnaire 
 
Please answer the following questions about your college experience truthfully.  
Stimulants refer to prescription medications including methylphenidate (Ritalin, 
Concerta, Metadate) and amphetamine (Adderall, Dexedrine, Desoxyn). 
 
Please circle the number that best describes your agreement with each statement. 
These questions are rated on a Likert scale:            Never    Rarely  Occasionally  Frequently  Always 
1.   I have used prescription stimulants for  
non-medical purposes.    1              2                3                   4                5      
2.   I have used prescription stimulants at parties. 1              2                3                   4                5        
3.   I have used prescription stimulants with alcohol. 1              2                3                   4                 5 
[Items 4-30 redacted; contact publisher for access to full measure]  
            
Please Circle Yes or No to the following questions: 
31. I know students who use prescription stimulants at parties.  YES        NO  
32. I know students who use prescription stimulants with alcohol. YES        NO 
33. I know students who use prescription stimulants with other drugs. YES        NO 
34. I know students who use prescription stimulants while studying.       YES        NO   
[Items 35-40 redacted; contact publisher for access to full instrument]  
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Appendix G: 
The Internal Restlessness Scale  
Following is a list of statements that people have used to describe themselves.   
Please indicate, in general, to what extent each one applies to you.  Be sure to 
answer all of the items. 
 
    None  Some  Most  All 
    of the   of the  of the  of the 
    time  time  time  time 
  
 
1.  I am organized.  1 2 3 4 5 6 7 
 
2.  I am told that I  
     interrupt people.  1 2 3 4 5 6 7 
 
3.  Thoughts race through 
      my head.   1 2 3 4 5 6 7 
 
4.  Mental restlessness 
     prevents me from  
     sleeping.   1 2 3 4 5 6 7 
 
5.  I am always thinking; 
     I have difficulty putting 
     thoughts to rest.  1 2 3 4 5 6 7 
 
[Items 6-24 redacted; contact publisher for access to full instrument]  
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Appendix H: 
Depression Anxiety Stress Scales – 21 
Please read each statement and circle a number 0, 1, 2, or 3 that indicates how much that 
statement applied to you over the past week.  There are no right or wrong answers.  Do 
not spend too much time on any statement. 
 
0 = Did not apply to me at all 
1 = Applied to me to some degree, or some of the time 
2 = Applied to me to a considerable degree, or a good part of time 
3 = Applied to me very much, or most of the time 
 
1.  I found it hard to wind down. 0 1 2 3 
     
2.  I was aware of dryness of my mouth. 0 1 2 3 
     
3.  I couldn’t seem to experience any positive feeling at all. 0 1 2 3 
     
4.  I experienced breathing difficulty (e.g. excessively rapid breathing, 
     breathlessness in the absence of physical exertion.) 
0 1 2 3 
     
[Items 5-21 redacted; contact publisher for access to full instrument]   
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Appendix I: 
Academic Self-Efficacy Scale 
Please rate your confidence in your abilities in the following areas.  
 
0 = Not at all Confident 
1 = Somewhat Confident 
2 = Very Confident 
 
1.  Completing your degree 0 1 2 
    
2.  Completing your degree in a timely manner. 0 1 2 
    
3.  Completing your degree at your current university 0 1 2 
    
4.  Your ability to pay for your graduate training 0 1 2 
    
[Items 5-10 redacted; contact publisher for access to full instrument]   
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